Wharton

MBA Program in Health Care Management

2017 RESUME BOOK Contents Program Description ...... 4 Curriculum ...... 5 Graduates ...... 6-32 Internship Sponsors...... 33 Health Care Program Mentors ...... 34-37 Administration ...... 37 Faculty ...... 38-39

Thank you for your interest in the Wharton MBA Program in Health Care Management. For further information, resumes, and appointments, contact:

June Kinney, Associate Director, MBA Program in Health Care Management The Wharton School University of 3641 Locust Walk , PA 19104-6218

215.898.6861 | Fax 215.573.2157 email: [email protected]

For information on the Wharton Health Care Management Alumni Association, visit www.whartonhealthcare.org

For detailed information on the Health Care Management Department educational programs, visit http://mba.wharton.upenn.edu/healthcare/ 2017 Health Care Management

M.B.A. Graduates The University of Pennsylvania was founded by Benjamin Franklin in 1740. Although the University carries the name of the Commonwealth, it is not a state university but an independent, private, nonsectarian institution. As one of the country’s earliest educational institutions, it has consistently initiated advances in teaching and research and has steadily generated specialized fields of higher education. Penn, as the University is commonly known, was the first American university to form departments of botany, hygiene and public health, surgical research, and research medicine. The University School of Medicine, formed in 1765, was the first in , as was the teaching hospital founded in 1874. The world’s first psychological clinic was opened at Penn in 1896.

The Wharton School, in the same spirit of innovation and excellence, was the world’s first collegiate school of and management. Founded in 1881 with a gift from Joseph Wharton, the Philadelphia industrialist and philanthropist, the Wharton School undertook the pioneer steps in elevating training for business significantly above its previous level as noncollegiate commercial education. In 1921, the formation of the Graduate Program signaled the advancement of business administration at Wharton to the highest levels of professional education.

Today, the Wharton School has more than 270 faculty members teaching in both the graduate and undergraduate divisions and conducting a continually expanding volume of research. The 1,700 students in the master’s degree program may choose from among more than 200 courses and over 18 majors and concentrations, a variety reflecting the fact that the Wharton education complements the career goals of the individual.

This brochure is provided to introduce you to the 2017 Wharton Health Care Management Program graduates.

We encourage you to consider these individuals for employment.

3 Program Description

The Graduate Program in Health Care Management The Leonard Davis Institute of Health Economics is a full-time two-year MBA curriculum offered (LDI) is an interdisciplinary center for research by the Health Care Management Department of and education in the organization, financing, the Wharton School. The program, the principal and delivery of health care. Through LDI, University educational effort at the Leonard Davis Institute of Pennsylvania faculty and staff work together of Health Economics, is designed to provide on issues concerning health policy, health managerial and technical expertise to students , managed care, hospitals, corporations, interested in the health care management field. pharmaceutical , and other health- By combining the skills of the Wharton disciplines related organizations. Established in 1967, the with sensitivity to the needs of health care providers Institute appropriately bears the name of the late and recipients, the Wharton MBA health care Leonard Davis, one of the foremost innovators in graduate can effectively manage the delivery of private health insurance in the . He health services and products at all levels. was the founder of Colonial Penn Group, Inc., a that has pioneered in insurance for older The Program has produced graduates who have Americans. Both Mr. Davis and Mrs. Sophie Davis chosen careers in hospitals and other medical were generous benefactors to the University of institutions, pharmaceutical, biotechnology and Pennsylvania, contributing basic support for the medical device companies, financial services, activities of the Leonard Davis Institute. entrepreneurial ventures, consulting firms, insurance firms, private health industry, and federal, state, and local government. Many of these MBA graduates now hold positions as chief executive officers, directors, and other key decision makers in health care organizations.

4 Curriculum The Wharton Management Core

All students are required to complete the Wharton Management Global Immersion Program Core. The Wharton School’s core curriculum is designed to The Wharton Global Immersion Program is an optional increase crossfunctional integration, extend global experience, half-credit elective course that provides first-year students strengthen leadership training, and introduce new courses with an in-depth exposure to international business on key management issues. The core curriculum provides practices and first-hand insights into a foreign culture. groundwork in basic management disciplines: economics, finance, financial and cost accounting, management , The Health Care Major Courses and Electives managing people and organizational design, marketing, These courses promote an understanding of concepts, operations management, the governmental and legal institutions, and issues involved in the organization, environment of business, statistics, and strategy. financing, and delivery of health services and products in the United States. Health care electives are selected Fixed Core: consistent with individual career objectives and interests. • Foundations of Teamwork and Leadership • Marketing Management Required • Quality and Productivity • Health Services System • Regression Analysis for Business • Health Care Field Application Project • Microeconomics for Managers • Management Electives • Comparative Health Care Systems Flexible Core: • Financial Management of Health Care Organizations Accounting • Managed Care, Market Structure, and • Financial Accounting or Health Care Delivery • Financial and Managerial Accounting or • Health Care Marketing • Accelerated Financial Accounting • Health Care Reform • Management and Economics of Finance: Corporate Finance Pharmaceutical and Biotechnology Industry • Corporate Finance or • Medical Devices • Accelerated Corporate Finance or • Management of Health Care for the Elderly • Introduction to Corporate Finance • E-Health: Business Models and Impact • Management of Health Care Services Finance: Macroeconomics • Health Care • Macroeconomics and the Global Economic • Private Sector Role in Global Health Environment or • Health Care Services Delivery: • Introduction to Macroeconomics and the Global A Managerial Economic Approach Economic Environment • Advanced Study Project

Legal Studies & Business Ethics The Health Care Summer Internship • Responsibility in Global Management or The internship is a three-month management experience • Responsibility in which provides the health care major an opportunity to work with a senior executive in an organization of Management particular interest to the student. • Managing the Established Enterprise or • Managing the Emerging Enterprise MBA Electives Opportunities are available for the health care major Marketing to pursue a second concentration in fields such as entre- • Dynamic Marketing Strategy or preneurship, marketing, finance, or operations, or to • Strategic Marketing Simulations pursue specialized knowledge in areas such as health care financing or within specialized segments of the health care Operations industry including managed care organizations, hospitals, • Business Analytics or pharmaceutical and biotechnology companies, medical • Information and Business Transformation or device companies, specialty services organizations, and • Innovation or long term care organizations. Graduate courses are • Operations Strategy available throughout the University. • • Advanced Persuasive Speaking or • Advanced Persuasion and Data Display or • Pitching Your Business

5 Animesh Agarwal Huda N. Almanaseer Mark Arpels [email protected] [email protected] Amez-Droz Indian Institute of Technology Madras, Northwestern University, Evanston, IL Chennai, India B.A., Psychology, 2011 [email protected] B.Tech., M.Tech., Biotechnology, 2009 Swiss Federal Institute of Technology (EPFL), University of Texas at Austin, Austin, TX Lausanne, Switzerland M.S., Biomedical Engineering, 2011 M.Sc., Biological Engineering, 2011

Business development role at An opportunity to improve patient care An opportunity to work in a corporate medical device, pharmaceutical through an operations or strategic role development or role to scale or biotechnology firm. in healthcare services. healthcare businesses.

Medtronic, , MN McKinsey & Company, , IL Medtronic, Minneapolis, MN Corporate Development Associate, Summer Senior Implementation Coach, Corporate Development Associate, Summer 2016 Summer 2016 Summer 2016 Developed an acquisition-based strat- Developed benchmarking standards Evaluated eight M&A opportunities. egy for Medtronic’s entry into renal for adult and pediatric health quality Was responsible for performing care services business in emerging metrics in a value-based care program financial valuations, identifying and markets. Participated in high-level and created dashboards to calculate quantifying synergies, and designing management meetings, including with healthcare cost-savings associated with earn-out structures to incentivize sell- CEO Omar Ishrak, to gain approval to quality improvements. ers based on Medtronic operational implement this strategy. Negotiated objectives. Ran point as lead associate a $40M supply agreement with India’s Northwestern Memorial Hospital, on two live deals, coordinating M&A largest private health system. Chicago, IL process and aligning stakeholders Operations and Performance Analyst, across the organization. Ventureast Venture , 2014-2015 Hyderabad, India Led development of $190M patient Monitor , Zurich, Switzerland Investment Analyst, 2011-2015 care budgets and constructed dynamic Senior , 2015-2015 Developed investment thesis for staffing workbooks utilized by front- Consultant, 2013-2015 ~$100M life- fund; evaluated line managers to make daily nursing Focused on strategy projects in the ~200 life-sciences investment deals, staffing decisions. Managed nurse and Pharmaceutical and Biotech sectors. conducted detailed due-diligence on technician staffing for 39 units / 1000 Select experiences include conducting 10 deals and pitched 4 deals to the FTEs and made hiring recommenda- commercial due diligence for M&A investment committee. Raised $5M tions based on analysis of volume transactions up to $1.1B, crafting in strategic investment from a pharma fluctuations and turnover. Designed market access strategies for novel investor for portfolio company with and launched pilot for an innovative drugs in European and Emerging mar- novel drug delivery mechanism to RN float pool program that created kets, and building market forecasts treat radiation-therapy side effects flexible multi-specialty teams. and scenarios for novel drugs. in head and neck cancer patients. Prepared investment memorandum Cancer Treatment Centers of America, Stroud Consulting, , MA and financial model to raise $10M , IL Associate Consultant, 2012-2012 for a super-specialty prosthetics-clinic Decision Support Analyst, 2013-2014 Focused on improving operations of chain. Management Fellow, 2011-2013 companies. Led teams Created interactive departmental of up to eight field engineers and University of Texas at Austin, Shouval performance dashboards in Qlikview operators to identify opportunities Computational Neuroscience Lab, business intelligence tool for executive for improvement and re-design Austin, TX leadership, including a 5-hospital phy- manufacturing processes. Research Assistant, 2009-2011 sician revenue dashboard. Completed Co-authored 3 peer-reviewed articles a 2-year accelerated leadership on stochastic analysis of biochemical development program consisting of networks in neurons responsible for rotations in core healthcare business modulating learning and memory. functions across hospitals and departments.

6 Alexander T. Andrew R. Barnell Simon Basseyn [email protected] [email protected] AuWerter (“Toby”) , Ithaca, NY University, New York, NY [email protected] B.S., Summa Cum Laude, Applied Economics B.A., Phi Beta Kappa, Summa Cum Laude, Duke University, Durham, NC & Management, 2011 Politics, 2011 B.S., Biomedical Engineering, 2009 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M.D. Candidate, 2017

An opportunity to use my life sciences Helping transform healthcare through An opportunity to integrate my clinical background to help develop and entrepreneurship. and business experiences to build commercialize new, life changing leading life sciences companies through therapeutics. Geneoscopy, St. Louis, MO investment, business development, or Chief Financial Officer, 2015-Present operational roles. Deloitte Consulting, Philadelphia, PA Defined the company’s business strat- Summer Associate, Summer 2016 egy as CFO of a 3-person management SR One, Cambridge, MA Managed the creation of a new, enter- team; managed fundraising, capital Biotech Intern, Summer prise-wide R&D organization at a lead- budgeting, business development and 2016 ing global biopharmaceutical company clinical trial execution plan. Raised Evaluated company formation and (market cap >$150B) along with proj- $270,000 in capital from investors and investment opportunities in microglia. ect leadership team. Led workstream $79,000 from non-dilutive sources. Advised portfolio companies on strate- to define vision for operating model, Planned and executed two clinical gic decisions. Screened incoming deal organizational design, and guiding trials; a 12-patient pilot study and a flow and conducted investment due principles for new organization. 400-patient validation study. diligence.

Juventas Therapeutics, Cleveland, OH Lindsay Goldberg, New York, NY McKinsey & Company, Philadelphia, PA Manager, Field Clinical Operations, Associate, 2013-2015 Summer Associate, Summer 2015 2014-2015 Evaluated new investment opportuni- Advised public sector client with a Field Clinical Engineer, 2012 - 2014 ties by building financial models, con- $20B budget on implementation of Led clinical development activities in- ducting due diligence, managing a statewide value-based physician cluding trial protocol and procedure advisors and preparing internal invest- payment program; oversaw client’s design efforts for Phase II HF and PAD ment committee materials. Managed progress in meeting federal reporting trials, including patient population portfolio by monitoring requirements associated with a selection and endpoint design. monthly financial and operational $3M grant; led client workshop on Developed cost effectiveness model, performance, analyzing strategic ac- web-based analytics tool for post- pricing and evidence generation strat- quisitions, evaluating engagement data analysis and egy, and reimbursement framework alternatives and collaborating with decision support. for JVS-100 gene therapy. management on implementing improvement initiatives. Center for Emergency Care Policy and St. Jude Medical, NY, NY Research, University of Pennsylvania, Senior EP-TSS, 2011-2012 J.P. Morgan, New York, NY Philadelphia, PA EP-TSS, 2010-2011 Healthcare IB Analyst, 2011-2013 Research Fellow, 2014-2015 EP Field Intern, 2009-2010 Performed valuation analysis using Co-developed methodology and inter- Certified in St. Jude’s electrophysiol- various methodologies, including: LBO preted data as lead or co-author of ogy and cardiac rhythm management valuation, DCF valuation, sum-of-parts studies published in New England product lines. Awarded national sales valuation, precedent transaction Journal of Medicine, Medical Care, and award for exceptional account growth. analysis and comparable trading Journal of General Internal Medicine, analysis. Selected top-tier analyst and investigating access to care, patient- ranked 1st among healthcare invest- centered medical homes, and health ment banking analysts in 2012 and care reform. 2013. Completed 14 total transactions: 3 buy side M&A, 3 sell side M&A, 1 IPO, 5 equity follow-ons, 1 convertible debt offering and 1 leveraged recapitalization.

7 K. Grace Bell Rachel L. Belzer Alessia Bhargava [email protected] [email protected] [email protected] Case Western Reserve University, Duke University, Durham, NC Yale University, New Haven, CT Cleveland, OH B.S.E., Biomedical Engineering, 2011 B.A., Magna Cum Laude, Economics, 2010 B.S., Management: Health Finance, 2010 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M.D. Candidate, 2017

An opportunity to grow leading health An opportunity to improve people’s An opportunity to transform our care technology and services businesses lives by building health care products mental healthcare system and promote through investment. that are enabled by data analytics and population mental health globally. innovative technology. Rittenhouse Ventures, Philadelphia, PA Aledade, Bethesda, MD Summer Associate, Summer 2016 Genetics, Seattle, WA Strategic Clinical Initiatives Fellow, Led due diligence for 3 Series A invest- Market Planning MBA Intern, Summer 2016 Summer 2016 ments within the health care vertical, Developed and prioritized a lifecycle Created depression toolkit to assist including conducting customer plan for an antibody drug conjugate primary care providers and care man- references, analyzing financials and (ADC) in the company’s pipeline to agers across 16 Accountable Care contributing to the design of all deal capture over 100,000 new patients in Organizations and 15 states better and term documents. Acted as resident the U.S. based on a quantitative analy- treat depression. Analyzed referral health care industry expert – inter- sis of commercial attractiveness and patterns and began formation of care preted key market trends and ana- ease of development for 17 potential contracts with high value specialists. lyzed and prioritized more than 40 opportunities. Presented recommenda- pipeline investment opportunities. tions to the entire commercial McKinsey & Company, , TX Advised two health technology organization including the EVP of Business Analyst, 2010-2011 portfolio companies to drive strategic Commercial and the VP of Marketing. Senior Business Analyst, 2011-2012 business initiatives regarding market Collaborated with ranking military opportunities and implementation Deloitte Consulting, Seattle, WA officers to inspire providers and processes. Consultant, Technology, 2013-2015 medical staff to implement Patient Business Technology Analyst, 2011-2013 Centered Medical Homes across Army NYC Department of Health and Mental Technology consultant focused on Medicine. Held working meetings with Hygiene, New York, NY digital strategy and data analytics the CEO of a children’s hospital to Health System Quality Manager, 2015-2015 for healthcare clients, including life amend C-level reporting structures Meaningful Use Services Manager, sciences, pharmaceuticals and health and re-design accountabilities of top 2013-2014 plans. Crafted three-year roadmap of level roles to incorporate service lines. Implementation Specialist, 2012-2013 digital initiatives, providing steps to Evaluated financial and organizational Worked with independent providers implement and sequenced timelines. synergies in a potential AMC merger; and Accountable Care Led project to create consistent order led analyses to recommend clinical Organizations to design and imple- status messaging across web and email service line reconfiguration between ment quality improvement projects for mail order pharmacy, increasing 4+ hospital sites to achieve >$100MM throughout . Managed customer awareness and decreasing in savings. a team to train physicians on over call center calls by over 7,000 calls per 80 distinct Electronic Health Record year. Developed customer data model, Publications: platforms, equaling $13M in federal allowing a life sciences client to master A. Bhargava, X.L. Du “Racial and grants. customer data for sales and marketing socioeconomic disparities in adjuvant strategy. chemotherapy for node-positive oper- , New York, NY able breast cancer in older women,” Clinical Operations Analyst, 2010-2012 Cancer 2009 (115: 13, 2999-3008). Restructured case management and perioperative departments in four academic medical centers to improve alignment, reporting and clinical practices according to industry best practice models.

8 Sourav Bose Ramon Burgos Jonathan Cagadas [email protected] [email protected] [email protected] University of Pennsylvania, Philadelphia, PA Harvard College, Cambridge, MA Northwestern University, Evanston, IL B.A., Magna Cum Laude, Biology and B.Sc., A.B., Government with Language Citation B.A., Economics & Financial Economics, 2011 Magna Cum Laude, Economics: Crisis in Chinese, 2008 University of Pennsylvania, Philadelphia, PA Management, 2011 Perelman School of Medicine at the University M.S. Candidate, Computer & Information School of Hygiene and Tropical of Pennsylvania, Philadelphia, PA Technology, 2017 Medicine M.D. Candidate, 2017 M.Sc. Public Health, 2012, Thouron Scholar, 2011-2012 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M.D. Candidate, 2017 An opportunity to integrate my medical An opportunity to build new products at and business experience to improve a healthcare technology company. healthcare delivery. An opportunity to transform maternal and pediatric surgical care delivery. IBM, Austin, TX Regeneron Pharmaceuticals, Product Manager Intern, Summer 2016 Tarrytown, NY McKinsey and Company, New York NY Led a team of 3 software developers Business Operations and Strategic Planning Summer Associate, Summer 2016 in building a new use case for IBM Intern, Summer 2016 Collaborated with medical and brand Watson’s predictive analytics platform. Engaged cross-functional teams across managers to develop the medical Created a cognitive cloud monitoring research, clinical, and finance affairs strategy and go-to-market plan and security tool to prevent cloud functions to establish a business devel- for a rare disease drug launch. network downtime and disruptions. opment strategy to support Regeneron Designed and implemented analyses Conducted end-user research, deter- Genetics Center research goals in including price factor, contract life mined product features, led daily human genetics and therapeutic cycle, and therapeutic equivalence to scrums, participated in code reviews, target discovery. Negotiated and identify $80M in cost savings opportu- conducted market and competitive executed two collaborations with nity in hospital supply chain and analysis, and built business plan for leading academic centers. Presented pharmaceutical procurement for product. recommendations to SVP of Strategy a large health system. and other senior commercial leaders. DaVita HealthCare Partners, The Children’s Hospital of Philadelphia, , CA Brigham and Women’s Hospital, Philadelphia, PA Manager, Corporate Development, Boston, MA Research Associate, 2015-present 2014-2015 Research Assistant, 2010-2012 Designed and implemented a study Senior Analyst, Corporate Development, Team launched patient recruitment to evaluate the cost-effectiveness of 2013-2014 for biobank in support of large-scale treating pediatric trauma patients in Analyst, Corporate Strategy, 2011-2013 human genetics research. Core respon- different clinical settings. Employed Transaction manager for DaVita’s sibilities included: coordinating and geographical informational systems to corporate development team, focused expanding patient recruitment in develop a network analysis of pediat- on M&A, JVs, and divestitures in the multiple clinical settings; obtaining ric trauma utilization. Conducted physician group sector. Led deal sourc- informed consent; data management; analyses to evaluate the effectiveness ing, valuation, and execution. Involved and preparation of IRB submissions. of various surgical ligation devices in in $600M of invested capital and a porcine model. expanded the company’s physician Nomura Corporate Research and Asset group presence into 3 new states. Management Inc., New York, NY Prioritized potential growth areas Credit Analyst, 2008-2010 for the company. Performed investment analysis and presented recommendations directly to portfolio managers on corporate debt investments in the industrial sec- tor totaling $250M. Responsibilities in- cluded: construction of financial models and projections; business risk assessments; and analysis of credit agreements.

9 Christine Casey Elizabeth L. Celata Steven T. Cupps [email protected] [email protected] [email protected] Duke University, Durham, NC The Wharton School, University of Harvard College, Cambridge, MA M.A., Spanish and Latin American Studies, Pennsylvania, Philadelphia, PA A.B., Cum Laude, Human Evolutionary Biology, 2010 B.S., Magna Cum Laude, Business and Public 2009 Policy and Health Care Management, 2011

An opportunity to serve health care An opportunity to improve patient care An opportunity to join an innovative companies interested in strategic and through developing and executing strat- team that is systemically transforming operational innovation. egies for biopharmaceutical companies. healthcare services by building better technology for providers, payers, or McKinsey & Company, Palo Alto, CA Takeda Pharmaceutical Company, consumers. Summer Associate, Summer 2016 Deerfield, IL Advised Fortune 200 biopharmaceuti- Commercial Leadership MBA Intern, Welltok, Newport Beach, CA cal CEO on the integration strategy, Summer 2016 Executive Intern to the CEO, Summer 2016 including salesforce redesign and Served as Strategy and Operations Led Strategic Planning process by product positioning, for a newly- intern to SVP of General Medicines coordinating 16 senior executives to acquired business unit. Conducted an Business Unit, gaining broad exposure develop an enterprise financing and assessment of a niche hospital supply across sales, marketing and managed capital plan, inorganic and organic market for a Fortune 500 medical markets organizations. Created and growth plans for 6 business units, and products company. facilitated workshops for 70+ partici- a go-to-market strategy. The plan was pants to help build understanding of presented to the Welltok Board and Avalere Health, Washington, DC new working model. Revised quantita- is being implemented. Also provided Senior Associate, 2013-2015 tive metrics and developed tracker to “Chief-of-Staff” type support to the Assessed the impact of the Affordable track progress aligned to organiza- CEO including special projects: internal Care Act on business strategy for phar- tional goals. Analyzed current vendors investment process improvement, cli- maceutical manufacturers and provid- and identified opportunities for ent-facing white paper development, ers. Conducted analysis on data about 30% reduction. Worked with 3 MBA “all-hands” material creation for 360+ prescription drug access and sources of interns to define a suite of marketing employees, and investor pitch support. insurance coverage to inform client materials to improve managed state and federal advocacy strategy. markets pull-through. , , CA Generated risk and opportunity Engagement Manager, 2015 assessments to evaluate coverage The , Associate, 2013-2014 and reimbursement of existing and Philadelphia, PA Senior Consultant, 2012-2013 new-to-market drugs. Consultant, 2013-2015 Consultant, 2009-2012 Associate, 2011-2013 Strategy consultant specialized in Advisory Board Company, Analyzed company and investor the Health and Life Sciences Practice. Washington, DC projections to set 3-5 year commercial Executed 21 projects for 18 clients Dedicated Advisor, 2011-2013 strategy for Global Pharmaceutical across payers, providers, biopharma, Research Analyst, 2010-2011 company. Identified growth opportu- and health tech. Focused on fee-for- Led implementation of competitive nities for mature brand through quali- value transformation, consumerism, intelligence software for 15 health tative research and sales data analytics and the convergence of healthcare systems. Collaborated with hospital ex- and supported execution of recom- with other industries. Spent 12 months ecutives to leverage data for strategic mendations including content devel- launching the Oliver Wyman Health planning and physician outreach. opment for sales meeting and creation Innovation Center, a collaborative Secured contract renewals through de- of executive scorecard. Worked with group of senior leaders from across velopment of ROI case studies. Secured client team to develop new operating healthcare with the mission of trans- $350K of new revenue in one quarter model for U.S. Oncology business to forming the sector. as lead consultant on proof of concept address changing market. contracts. Won executive support by identifying client needs and imple- menting pilot projects through inten- sive engagements. Conducted 1 to 6 month research studies to surface op- portunities in hospital payment and delivery reform.

10 Alexander P. Siddharth Damania Vikram A. Dashputre [email protected] [email protected] D’Amato Stanford University, Stanford, CA University of North Carolina, Chapel Hill, NC [email protected] B.A., Economics, 2012 B.S.B.A., Highest Distinction, Business Adminis- Princeton University, Princeton, NJ M.A., Public Policy, 2012 tration and Economics, 2010 A.B., Magna Cum Laude, Sociology, 2009

An operational opportunity to improve An opportunity to build new health An operational role with an organiza- the managed care system through care businesses through an operational tion improving healthcare delivery. increased efficiency and effectiveness or strategic role. as reflected in patient cost, quality and DaVita HealthCare Partners, , CO outcomes. Medtronic, Minneapolis, MN Redwoods Summer Associate, Summer 2016 Business Development Summer Associate, Developed business case for risk-based UnitedHealthcare, Minnetonka, MN Summer 2016 relationships with partners managing Strategic Initiatives Intern – Community Developed the product, technology, small populations. Proposed strategy & State, Summer 2016 and market strategy for a new con- to manage risk internally, and recom- Various operational projects for sumer disease management device, mended specific payment structures Medicaid state plan leadership. representing a 4M U.S. patient oppor- and types. Designed a holistic operating model tunity. Designed novel business models for members with commercial as well for nascent type II diabetes business, Enhanced Equity Funds, New York, NY as managed Medicaid coverage developing with pharma Private Equity Associate, 2013-2015 (children with special needs) across and technology companies and identi- Evaluated investment opportunities five plan functions. Developed fying market expansion strategies for at healthcare services private equity improved process and procedures existing portfolio. firm with $600M under management. for state MMP reporting procedures. Worked with portfolio companies Oliver Wyman, New York, NY to coordinate due diligence, deal Evolent Health, Arlington, VA Associate, 2015 execution and refinancing processes Director, 2013-2015 Senior Consultant, 2014 related to add-on acquisitions. Associate Director, 2012-2013 Consultant, 2012-2013 Supported management teams in Senior Analyst, 2011-2012 Managed teams to deliver fact-based budgeting, strategic planning and Worked with other founders as com- solutions for executives, with a focus capital structure decisions. pany’s fourth employee to establish on health services. Key projects business plan, create financial models, included an enterprise redesign for a NewYork-Presbyterian Morgan Stanley and review results with potential top 10 healthcare system, the develop- Children’s Hospital, New York, NY customers and investors, which ment of a novel fraud detection Morgan Stanley Ambassador, 2012-2013 culminated in $20M initial funding. process for a federal agency (80x ROI), Selected by Morgan Stanley to spend Developed several generations of new and a due diligence of medical clinics a year supporting strategic initiatives products for firm. Ultimately oversaw to inform a PE investment decision. at NewYork-Presbyterian Hospital. staff that built new business case Recipient of Client Award, recognizing Managed project to design a clinical models and set pricing for new clients project work with the greatest client pathway for pediatric asthma. resulting in $130M in revenue. impact. Led committee to improve patient throughput and created dashboards Dean & Company, , VA Spiritual Nutrients, Minneapolis, MN monitoring hand-off issues, turn- Analyst, 2009-2011 Consultant, 2012-Present around time and best-practice Designed and created analytical model Grew natural products family business compliance. to prioritize infrastructure investments by 50% by developing customer acqui- for a major wireline telecommunica- sition strategy and creating a suite of Morgan Stanley, New York, NY tions provider in the high-speed online brand management products. Healthcare Analyst, internet market. Created pitch decks to secure 25% 2010-2012 of new customer relationships and Supported execution of M&A and capi- first-ever exclusive contracts. tal-raising transactions for healthcare sector clients, including Alkermes’ $1B merger with EDT and Sigma-Aldrich’s $350M acquisition of BioReliance.

11 Timothy J. Daubert Allison E. Dender Harris C. Drantch [email protected] [email protected] [email protected] Lafayette College, Easton, PA Washington University, St. Louis, MO Indiana University, Bloomington, IN A.B., Magna Cum Laude, Biochemistry, 2009 M.S. Finance, Knight Scholar, Beta Gama B.S., With Honors, Finance, 2010 Sigma, 2010 B.S.B.A., Magna Cum Laude, Finance and International Business, 2010

An opportunity to build and grow an An opportunity in private equity to An opportunity to make a significant innovative early-stage digital health identify, build, and transform market- contribution to the growth and company. leading healthcare companies. development of an early stage health care company. Nuna Health, San Francisco, CA Community Veterinary Partners Strategy Intern, Summer 2016 (Portfolio company of Cortec Group), New Capital Partners, Philadelphia, PA Conducted market segmentation and Philadelphia, PA CxO Associate – Medsurant Holdings, competitive landscape analysis for MBA Intern and Board Observer, Summer 2016 a healthcare data science startup. Summer 2016 Worked as part of Medsurant’s senior Worked with the CEO and senior lead- Analyzed opportunities for opera- management team on a variety of ership to refine company pitch deck; tional improvement across 21 hospitals strategic projects including: identifying participated in Business Development for President and CFO. Motivated opportunities to increase net revenue meetings with prospective clients; col- practice managers to implement price per case, standardizing clinical laborated with Product Development increases that add $500,000 of annual practices, reorganizing outside sales team on product strategy. revenue. processes and improving billing / collections efficiency. Identified an The Advisory Board Company, Sentinel Capital Partners, New York, NY opportunity to increase net revenue Washington, DC Private Equity Senior Associate, 2014-2015 per case by ~13%, presented findings Director, 2014-2015 Private Equity Associate, 2012-2014 to regional presidents and developed Associate Director, 2012-2014 Evaluated, executed, and monitored a plan to implement related improve- Senior Business Analyst, 2011-2012 investments for top quartile private ments. Managed Implementation and equity firm investing a $1.3B fund. Support teams for the Surgical Managed Associates and third party Wafra Partners, New York, NY Profitability Business Intelligence pro- to execute leveraged Assistant Vice President, 2013-2015 gram, an operational efficiency and and add-on acquisitions. Associate, 2012-2013 cost containment technology serving Board Observer of Hospice Advantage, Identified, evaluated, and executed 130+ hospitals and health systems na- Corporate Visions, North American investments for a consolidation strat- tionwide. Restructured business ana- Rescue, and Critical Solutions egy focused private / growth equity lyst teams into cross-functional model, International. Completed leveraged firm (latest fund $300M). Monitored leading to 30% reduction in imple- of Hospice Advantage, exe- existing portfolio company perfor- mentation timelines and 40% decrease cuted buy and build investment thesis mance through attending board meet- in support request completion time. by leading 13 acquisitions, and sold to ings and performing regular valuation Founded Cost & Operations Innovation Hospice Compassus in three years. / alternatives analyses. Worked with Initiative and led 150-person depart- existing portfolio companies on ment in 2013 and 2014 innovation Piper Jaffray, New York, NY executing strategic projects and campaigns. Investment Banking Analyst, 2010-2012 acquisitions. Advised on and executed middle Oracle Corporation, Philadelphia, PA market leveraged buyouts, mergers Cain Brothers & Company, Senior Consultant 2010-2011 and acquisitions, public and private New York, NY Staff Consultant 2009-2011 capital raises, and competed for Analyst – , Established and maintained trusted prospective investment banking 2011-2012 partnerships with pharmaceutical mandates. Executed middle market leveraged clients as a dedicated resource for buyouts, private capital raises, and designing over 20 clinical drug trial strategic mergers and acquisitions management software implementa- for a variety of health care services tions. Coordinated internal develop- companies. ment teams to ensure complete programming and validation; conducted in-depth user acceptance testing to verify client deliverables.

12 Raul Estrada Kenneth W. Ewell Kevin T. Fennell [email protected] [email protected] [email protected] ITESM, Monterrey, Mexico Princeton University, Princeton, NJ University of , Ann Arbor, MI B.Sc., Summa Cum Laude, Biotechnology A.B., Economics, 2009 B.B.A., With High Distinction, Phi Beta Kappa, Engineering, 2011 Finance 2012

An opportunity to develop and execute An opportunity to build and work An opportunity to launch and imple- innovative strategies for health services on effective teams within health care ment new products, services and operat- or biotech companies. services or devices, with responsibility ing models that improve the efficiency, for both operations and strategy. affordability and quality of patient care. DaVita Healthcare Partners, Denver, CO Redwoods Summer Associate, Summer 2016 Medtronic, Minneapolis, MN Aledade, Bethesda, MD Developed a predictive model to iden- Product Strategy, Summer 2016 Summer MBA Intern, Summer 2016 tify key drivers of patient enrollment Identified and presented opportunity Oversaw development of pitch materi- for Paladina Health (direct primary to General Manager to enter new als for new business opportunities, care) analyzing more than 30 variables $120M+ market with implantable including new equity and debt financ- and 97% of covered lives. Identified remote patient monitor; initiated ing, partnerships with 3 regional and prioritized 20 initiatives to pilot study discussion with hospital, commercial payers, and proposed increase enrollment which became recommended next steps. Analyzed management contract for a physician- the team’s strategic scorecard. economic value case using payer data- led Accountable Care Organization set; identified $12M in annual system with over 40,000 covered lives. Bill & Melinda Gates Foundation, savings achievable within 5 years. Developed financial projection tool to Seattle, WA Sourced and conducted interviews estimate impact of regulatory changes Integrated Development Associate, with 6 leading surgeons to understand (e.g., Merit-based Incentive Payment 2014-2015 status quo and market needs; negoti- System) and value-based care opportu- Strategy and project manager for ated, commissioned, and managed nities (e.g., Medicare Shared Savings the Diagnostics team. Projects include qualitative market research study. Program) for new potential practices. leading a team of two to assess the Received highest rating from manager. viability of a US $500M multi-disease, Strategy& (formerly Booz & Company), point-of-care diagnostic tool for com- Quvat Capital Partners, Singapore Chicago, IL munity health centers in sub-Saharan and Jakarta, Indonesia Associate, 2014-2015 Africa, and acting as the project man- Junior Associate, 2014-2015 Consultant, 2012-2014 ager for the Foundation’s Ebola 2014 Senior Analyst, 2013-2014 Strategy consultant for firm’s health- outbreak diagnostics response team. Evaluated, managed, and exited care clients, including health systems emerging markets investments for and health insurance companies. Bain & Company, Mexico City, Mexico $500M Indonesian private equity fund. Project work included customer Senior Associate Consultant, 2014-2015 Led individuals and cross-cultural experience strategy, new product Associate Consultant, 2012-2014 teams in transactions in Indonesia, development and channel strategy, Strategy consultant across sectors, with Korea, and China. Initiated and led M&A integration, and operational clients in Pharmaceuticals, Financial training and mentorship program for improvement. Project highlights: (1) Services, CPG, and Industrial Goods 12+ junior analysts; named Head of developed customer experience strat- industries. Project experience includes Training by CEO. egy for regional health plan, identify- performing a commercial due ing >$200M in operating income diligence on leading biosimilars Princeton in Asia, Manila, Philippines potential through improved efficiency manufacturer, identifying regulatory Nonprofit Fellow, 2011-2012 and growth in customer sales, (2) led and competitive risks for existing cost analysis and vendor capability and pipeline products. Performance J.P. Morgan Securities, LLC assessment for operational transfor- trajectory assessed as “frequently Analyst, Healthcare Investment Banking, mation at regional health plan, exceeding expectations.” 2009-2011 resulting in $1B in organizational Executed debt, equity, and M&A trans- investment for operations and actions, and competed for prospective technology redesign. investment banking mandates on three- to five-person teams.

13 Gonzalo T. Ferrer Matthew R. Filer Jeffrey M. Fiore [email protected] [email protected] [email protected] Texas Christian University, Fort Worth, TX The University of North Carolina, Washington University in St. Louis B.B.A., Summa Cum Laude, Finance, 2010 Chapel Hill, NC B.A., Honors, Economics, Psychology, 2010 B.S., Business Administration 2009

An opportunity to work in the health Seeking investment opportunities An opportunity to work with a dynamic care services space in a role that in growing, lower middle market healthcare company leveraging technol- combines strategy and operations. healthcare companies. ogy to improve health care services.

Bain & Company, , TX Ventus Health Investors, Teladoc, Purchase, NY Summer Associate, Summer 2016 Philadelphia, PA Corporate Strategy and Product Worked on a digital transformation of Managing Partner, 2016-Present Management Intern, Summer 2016 a large bank. My work focused on the Lead deal sourcing, investment Led market research, partnership utilization of data for decision making due diligence, fund operations and strategy and product definition for and program performance evaluation. investor relations for a small, private offering in $32B physical therapy investment fund. market from inception to initial DaVita Healthcare Partners, Denver, CO design. Analyzed health system Manager – Special Projects, 2013-2015 Nautic Partners, Providence, RI telehealth market and recommended Co-led team for a rapidly growing new Healthcare Private Equity Associate, strategic position relative to electronic patient education program, utilizing 2012-2015 health record vendors. data to drive insights, identify oppor- Responsible for investment due tunities, and execute improvements. diligence, deal execution and portfolio Ernst & Young Healthcare Advisory, Managed data and analytics team and company strategy for a $3B middle New York, NY a team of social workers. market private equity fund. Senior Consultant, 2014-2015 Investment experience across health- Staff Consultant, 2013-2014 VMG Health, Dallas, TX care sectors, including post-acute care, Advised health systems in revenue Senior Analyst, 2010-2013 home care, behavioral health, urgent cycle operations and IT optimization. Led financial statement analysis and care, disease management and Projects included revenue cycle due diligence for transaction-driven medical practice management. modernization for Mayo Clinic and im- equity pricing of privately owned plementation of a centralized Patient companies in various areas of the Deloitte Consulting, , GA Access unit for the University of health care services industry. Consultant, 2011 Virginia Health System. Co-led team Business Analyst, 2009-2011 to improve offerings supporting Strategy consultant to Fortune 500 Epic Systems resulting in over $10M retail and consumer products compa- of client contracts. nies. Led small teams of junior consul- tants in delivering strategic planning, Epic Systems, Madison, WI organic growth strategy, new market Application Manager, 2012-2013 entry, and pricing strategy engage- Application Coordinator, 2010-012 ments. Managed multi-million dollar implementations of Epic’s revenue cycle applications. Advised clients post- implementation in system optimiza- tion including a project at Froedtert Health System resulting in perfor- mance statistics in top 10% of customers. Directed internal team in preparing best-practice recommenda- tions and setting direction for future development.

14 Prerak Garg Andrew Goberstein Julia S. Goldner [email protected] [email protected] [email protected] The Young India Fellowship, New Delhi, India Bentley College, Waltham, MA Brown University, Providence, RI Postgraduate Fellowship in Liberal Studies, 2011 B.S., Finance, 2009 Sc.B., Magna Cum Laude, Biomedical Indian Institute of Technology, Kharagpur, India Engineering, 2011 B.Tech., With Honors, Chemical Engineering, 2010

An opportunity to operate and invest An opportunity to build successful A strategic or operational role within a in successful healthcare businesses healthcare businesses through a private mission-driven organization focused on through private equity or venture equity investing role. delivering or supporting value-based, capital in Asia. innovative care. Frazier Healthcare Partners, Seattle, WA McKinsey & Company, Summit, NJ Summer Associate, Summer 2016 Accolade, Plymouth Meeting, PA Summer Associate, Summer 2016 Evaluated middle-market, private Strategy / Operations Innovation Intern, Led 6 performance transformation equity investment opportunities in the Summer 2016 projects including portfolio and prod- healthcare sector. Executed platform Worked with Chief Strategy Officer uct complexity reduction, network investment of a dermatology group. to develop internal perspectives on consolidation, material cost reduction, pursuing the health system market and operations restructuring with Court Square Capital Partners, and on value-based reimbursement $325M NPV for a $70B sales global New York, NY dynamics. Worked with the VP of healthcare firm. Private Equity Associate, 2012-2015 Operations Innovation to complete in- Assessed investment opportunities, depth cost-of-service analysis to better Cipla Ltd, Mumbai, India performed financial and business due understand Health Assistants’ time and Head, Global Supply Chain Transformation diligence and assisted portfolio com- productivity improvement opportuni- Office, 2014-2015 pany managers for private equity firm ties. Conducted internal interviews to Manager, Global Supply Chain with over $6B in AUM. Completed two identify operational considerations Transformation Office, 2012-2014 portfolio company sales (Western and effort required to support a new Led 20+ projects across 5 departments Dental and The Harvard Drug Group), product launch. in order to arrest decline in firm’s an add-on acquisition for The Harvard growth rate. Increased revenue Drug Group, and a dividend recapital- Oliver Wyman, Health & Life Sciences, growth 2.5x for $800M export business ization for The Harvard Drug Group. New York, NY by setting up 35 cross-functional teams Worked with an operating partner to Engagement Manager, 2015 and improving on-time delivery 4x develop an investment thesis in HCIT Associate, 2014 for 23,000 SKUs in 160 countries. by performing industry research, iden- Consultant / Senior Consultant, 2011-2013 Introduced best practices in procure- tifying attractive sub-segments of Worked with health insurers and pro- ment, saving $12M annually. Spear- HCIT, and identifying companies viders largely focused on transforming headed post-merger turnaround of within those sub-segments to invest. toward value-based care. For a large $103M acquisition in Africa, achieving regional insurer, coordinated product $5M in savings and 50% revenue J.P. Morgan Securities, New York, NY design and network contracting for growth in 1 year. 1 of 2 employees Group Analyst, 2009-2012 one Medicare Advantage and two recognized by CEO for role in transfor- Executed leveraged finance, M&A and commercial individual products for mation. equity transaction on behalf of large- 2015 launch. For a large regional cap and middle market private equity provider, developed 5-year financial Office of Naveen Jindal, Member clients. Provided secondary coverage projection with client’s budgeting, of Parliament, New Delhi, India on Apollo, GTCR and BC Partners. finance, and clinical integration teams Consultant Intern, 2011-2012 Transaction experience included to demonstrate impacts of managing Conceptualized and implemented financing The Carlyle Group and population health. For various proj- development initiatives worth $10M Hellman & Friedman’s leveraged ects, deployed surveys, conducted ex- in 1,100 villages in rural India. buyout of Pharmaceutical Product pert/consumer interviews, facilitated Development, financing Veritas’ workshops, and led teams of 2-4 Indian Oil Corporation Ltd, of Truven Analytics, consultants to meet client needs. Barauni, India and underwriting The Carlyle Officer, 2010-2011 Groups’ IPO. Advised Deputy General Manager of the largest refinery in the region (6 MMTPA) on re-modeling various units and increasing efficiency.

15 Julie S. Goodman Glen Elizabeth Jason Han [email protected] [email protected] Cornell University, Ithaca, NY Graves University of Pennsylvania, Philadelphia, PA B.S., Operations Research and Engineering, [email protected] B.A., /B.S., Finance, Life Sciences 2011 Northwestern University, Evanston, IL and Management Program, 2010 B.S., Social Policy, Economics, 2010

An opportunity to transform care deliv- An opportunity to work with dynamic A growth oriented operational role ery through an operational or strategic teams at the intersection of health care that combines my provider and analytic role at a health care technology com- strategy and policy. experiences to make an impact in pany. patient care. McKinsey & Company, Denver, CO athenahealth, Watertown, MA Summer Associate, Summer 2016 Clover Health, Jersey City, NJ Clinical Operations MBA Intern, Worked on supply chain initiative for New Markets Intern, Summer 2016 Summer 2016 national hospital system. Worked with Developed analytics dashboards to Collaborated with providers and ad- client leadership to evaluate existing enable network management team ministrative staff to reduce the time best practices and develop standard- to drive profitability in local markets. providers spend documenting in ized monthly performance metrics and Built operations workflow tool to sup- athenaClinicals outside of encounters. reporting processes. port physician contracting, credential- Utilized analytics tools to identify and ing, and network expansion. assess 12 opportunities to shift the DaVita Healthcare Partners, Denver, CO co-sourcing model so that athena can Manager & Senior Analyst, Special Projects, New York Presbyterian, New York, NY take on a greater breadth and depth 2013-2015 Manager, 2012-2015 of client work. Presented recommen- Senior Analyst, 2012-2013 Led the project management / consult- dations on process redesign and Redwoods Analyst, 2010-2012 ing team of 9 within the clinical best practice initiatives to CEO and Partnered with integrated care leader- analytics department. Partnered and executive leadership. ship to develop innovative clinical ser- engaged with front-end clinicians in vice offerings with external partners, the design and implementation of Deloitte Consulting, LLP, Boston, MA including an Accountable Care Health IT solutions. Hosted the first Consultant, 2013-2015 Organization and an insurance Hackathon at NYP to identify opportu- Business Technology Analyst, 2011-2013 company. Oversaw field operations, nities to reduce patient length of stay Primarily served large health insurance external partnerships, and growth at the hospital. companies, focusing on improving strategy in nine states for Kidney operational efficiencies through tech- Smart, DaVita’s kidney disease educa- , New York, NY nology-enabled solutions. Led deliver- tion program. Set agenda and drove Analyst, 2010-2012 ables, managed client expectations, strategic operations and policy Published “Thought Leadership: and cultivated junior practitioners as solutions as part of a multi-team Building on Meaningful Use: Three pivotal member of service delivery healthcare exchange working group. Opportunities for High Performance.” team. Collaborated with IT and Developed and owned healthcare Managed collaborative work team to business teams to drive prioritization, exchange five-year financial model. build system-wide metrics scorecard analysis and resolution of operational Managed program analytics, consisting of 30 members, including challenges. Managed, initiated, and forecasting, and reporting team. CMIOs, service line directors, and implemented new processes and clinical leadership across 12 facilities to increase operational for a large catholic healthcare system. efficiencies.

16 Nathalie J. Herman Brandon Holler Yang Hu [email protected] [email protected] [email protected] Wellesley College, Wellesley, MA Northwestern University, Evanston, IL University of Pennsylvania, Philadelphia, PA B.A., Magna Cum Laude, Economics and B.S, Industrial Engineering and Economics, B.A., Summa Cum Laude, Economics, 2012 French, 2011 2008

An opportunity to work on a dynamic An opportunity to work with a dynamic An opportunity to improve healthcare team within health care consulting, mission driven team to deliver rapid access for developing countries or rural with focus on biotech and diagnostics. growth at a health technology company. communities through technology and strategy. LEK Consulting, Los Angeles, CA Quartet Health, New York, NY Summer Consultant, Summer 2016 Business Development MBA Intern, Summer Clinton Health Access Initiative, Collaborated with cancer diagnostic 2016 Phnom Penh, Cambodia company to develop short and long- Developed an economic model to Volunteer, Summer 2016 term biopharmaceutical partnership quantify value proposition to hospitals Conducted an assessment of financial strategy; identified and prioritized top and health systems operating in management systems at the National biopharmaceuticals for $100M+ collab- various fee-for-service reimbursement Malaria Center (CNM), Ministry of oration. Performed due diligence on environments and those transitioning Health in Cambodia with an objective $30M revenue regulatory lab testing to value-based reimbursement envi- to increase spending of $18M interna- company; conducted 15-20 key opin- ronments. Supported sales campaigns tional grants. Developed a Grant ion leader and customer interviews; and codified a customer journey Management Manual to formalize the identified and quantified five revenue playbook including tool templates, policy and procedures for spending and three cost-based synergies and business guidelines and key and managing grants awarded to developed purchase recommendation milestones. Led scan of partnership CNM. Developed a new Cambodia to support acquisition. landscape to augment capabilities. national forecasting tool for malaria drugs and diagnostics. The Amundsen Group, an IMS Health HealthScape Advisors, Chicago, IL Company, San Francisco, CA & Manager, 2014-2015 Deloitte Consulting, New York, NY Boston, MA Senior Consultant, 2011-2014 Consultant, 2014-2015 Consultant, 2013-2015 Strategy and operations consultant Business Analyst, 2012-2014 Associate Consultant, 2011-2013 for health plan clients and risk-bearing Strategy and operations consultant for Collaborated with top 10 large phar- provider systems. Advised clients clients across pharmaceutical, biotech- maceutical companies to develop and through pre and post-ACA implemen- nology, health plans, providers, and implement revenue maximizing strate- tation challenges including risk adjust- health care technology sectors. Sample gies. Designed physician and payer ment impacts and exchange strategy. projects include 1) developing cost market research surveys and interview Led health plan behavioral health reduction and process improvement guides to understand physician strategy transition over 24 months initiatives resulting in over $1M in prescribing and payer coverage for through assessment, sourcing, savings for a regional hospital system; pre-launch high cost specialty drugs; contracting and implementation 2) team lead for the design and imple- conducted physician and payer inter- securing over $90M in savings. mentation of Connecticut’s Health views; developed optimal launch Insurance Exchange mandated by strategies based on healthcare market FTI Healthcare, Chicago, IL Obama Care; 3) creating a knowledge landscape. Delivered client site presen- Senior Consultant, 2011-2011 management tool for a global tations outlining optimal launch strat- Consultant, 2008-2010 biotechnology client to cover over egies, contracting recommendations Performance improvement consultant 100 molecular, imaging and clinical between the drug manufacturer and for hospital and health system clients trial databases. payers, and loss trajectories. including revenue cycle improvement, service line analysis, supply chain management, and labor productivity. Led analytical development of new Clinical Effectiveness service offering using comparative statistical analysis to identify physician variation and track financial and clinical impact of process redesign.

17 Erica A. Jain Shubhra Jain, M.D. Amit Jayakar [email protected] [email protected] [email protected] Duke University, Durham, NC Stanford University, Stanford, California Georgetown University, Washington, DC B.A. Health Disparities and Infectious Diseases, Masters in Mechanical Engineering, 2012 B.A., Economics and Mathematics, 2009 2011 Kasturba Medical College, Manipal, India Bachelor of Medicine & Bachelor of Surgery, 2010

Opportunity to improve healthcare An opportunity to use my clinical, An opportunity to combine my access and delivery through innovative technical and business skills to build in- experience in technology and finance care models and technology. novative health care companies. to improve healthcare delivery models.

Healthie, New York, NY Bank of America, New York, NY Wellthie, New York, NY CEO & Co-Founder, 2016 Summer Associate, Healthcare Investment MBA Business Development Intern, Healthie is a practice management Banking, Summer 2016 Summer 2016 solution for nutrition professionals. Analyzed credit risk considerations Managed fundraising process for Providing an all-in-one solution for for a $1B Term Loan refinancing for Wellthie’s first institutional investment scheduling, billing, charting, HIPAA- a $30B Healthcare Services Client. round, and created sales infrastructure compliant telehealth, and patient Identified potential bolt on M&A tar- for prospects with our new core prod- communication. Nutritionists practice gets and executed due diligence for a uct. Developed resource requirements more efficiently with improved client $655M sponsor acquisition financing to navigate funding strategy and outcomes. Healthie graduated from of a medical device company. communication to potential investors. Techstars NYC. Successfully closed on the initial Red and Blue Ventures, Philadelphia, PA $500,000 and signed the first Boston Consulting Group, Dallas, TX Summer Associate, Venture Capital, enterprise broker customer. Management Consultant, 2011-2015 Summer 2016 Due diligence for $22B Private Equity Conducted due diligence on 15 Children’s Hospital, Miami, FL Fund. Cost/profitability drivers, projec- Healthcare IT deals. Sourced 50 deals Business Specialist, 2014-2015 tions, 10-year hospital growth strategy/ over 5 weeks by leveraging personal Developed pilot model for a $50M governance design for top Uni versity connections with entrepreneur service line to assess the financial Medical Center. Trans formed Customer forums. feasibility of value-based health Service design for Nationwide care in a regional pediatric hospital. Pharmacy for 2% increased revenue. Parkland Center for Clinical Innovation, Responsibilities included negotiating Cost reduction/strategic redesign for Dallas, TX a $5M bundled payment surgery Multinational Pharmaceutical Company Product Manager, 2014-2015 contract with multiple commercial with a $1.6B impact on a prestigious Led conceptualization and develop- insurance payers, and benchmarking project (Tel Aviv/ Paris). ment of clinical prediction and the base-line economics of the hospital surveillance software for U.S. hospitals and insurance carriers. Clinton Health Access Initiative, and health systems including a $2.3M East Africa/USA IT solution which reduced mortality by Vista Equity Partners, San Francisco, CA Program Analyst, New Initiatives – 17% and enhanced treatment compli- Senior Analyst, 2011-2014 Nutrition Program, 2013 ance by 100% at a 1000 bed hospital. Led transaction diligence efforts for Strategic team to combat malnutrition the evaluation and execution of for 26M infants in Ethiopia, Rwanda, Independent Consultant, Sunnyvale, CA eight software company acquisitions Kenya, Uganda. Economic feasibility, Independent Consultant, 2011-2014 accounting for roughly $2B across strategy to generate donors and pri- Developed go to market strategies, multiple verticals including healthcare, vate investors. Designed multinational competitive analysis, growth prioritiza- energy, and transportation. distribution system for baby food to tion, resource forecasts and strategic reach ‘the last mile,’ financial models plans for Fortune 500 Clients and for the dairy and sugar industries. startups. Structured subsidy program to ensure affordability by leveraging Rwanda’s Ubudehe socioeconomic system and The World Food Program adopted by Ministries of Health and Agriculture.

Multiple Research and Publications

18 W. Tyler Jorgensen Kunal Kandimalla Matthew L. Katz [email protected] [email protected] [email protected] Yale University, New Haven, CT University of Pennsylvania, Philadelphia, PA Wesleyan University, Middletown, CT B.S. Applied Mathematics, 2010 B.A., Cum Laude, Economics, 2010 B.A., Honors, Economics & Government, 2011

An opportunity to improve patient An investment or operational opportu- An opportunity to lead strategic and outcomes through technology, strategy, nity focused on building successful operational improvements to value- and operations. companies in the life sciences and based care arrangements. adjacent sectors. Medtronic, Santa Rosa, CA Cigna, Philadelphia, PA Leadership Development Rotational Program Novartis, , Switzerland Value-Based Reimbursement Summer Summer Associate, Summer 2016 MBA Intern, Corporate Strategy, Associate, Summer 2016 Worked on contracting strategy and Summer 2016 Designed and executed comprehensive engaging a new customer segment in Assisted with company-wide 5-year study of Cigna’s ACO support model. the aortic business. strategic planning process for Identified key value drivers from pro- Executive Team offsite. Helped with vider perspective. Research included Picwell, Philadelphia, PA operational framework for novel over 40 internal interviews, 10 external Senior Data , 2013-2015 managed care business focused on interviews with ACO provider leaders, Developed health plan recommenda- using digital health technologies to and extensive analysis of national sur- tion system, first for Medicare and manage enrollees. Conducted compet- vey data. Presented final report and later for commercial insurance plans. itor benchmarking and drafted memo strategic implications to a variety of Products were deployed with a large for CEO on competitor digital health company leaders including the CMO benefits manager and a large health strategies. and multiple VPs. insurer. Agios Pharmaceuticals, Cambridge, MA Blue Shield of California, Anapsis, San Francisco, CA Manager, Business Development & El Dorado Hills, CA Cofounder, 2013 Operations, 2014-2015 Intermediate Configuration Analyst, Gained acceptance to Rock Health Analyst, Business Development & 2014-2015 accelerator. Developed a web-based Operations, 2014 Associate Configuration Analyst, 2012-2014 platform through which analysts and Assessed, presented and offered deal Performed data analysis, solution engi- data could share, collaborate support on early-stage in-license op- neering, and testing for suite of insur- on, and run analytical code to portunities. Conducted financial, com- ance software. Ensured new systems make their work more accessible, mercial and scientific due diligence on supported business processes by transparent, and repeatable. existing and new development pro- collaborating closely across internal grams. Assisted in corporate develop- teams. As member of newly formed ZS Associates ment initiatives requested by Executive internal testing team, designed and Business Analytics Associate, 2010-2012 Team and BOD, including drafting implemented workflows and standard Developed the sales force strategy for buy-side business development strat- operating procedures. Headed testing a biotech client to launch a prospec- egy, creating franchise co-promotion of new software extension, identifying tive $10B peak revenue brand. Led the models and evaluating ex-U.S. partner- three critical design flaws and analytics on an internal research proj- ing options for pipeline drug. directing troubleshooting to meet ect to develop statistical models that go-live date on time. provide individualized promotional Putnam Associates, Boston, MA messages. The models were later incor- Consultant, 2014 Operations Management Trainee, porated into a product deployed at Analyst, Associate & Senior Associate, 2011-2012 two pharmaceutical companies. 2010-2013 Completed competitive rotational Led teams in advising top 10 pharma- program across Installation & ceutical companies on 25+ projects, Membership, Customer Service, and including revenue forecasting, market Claims departments. Conducted three and opportunity analysis, brand posi- process improvement projects as tioning and growth strategy, pricing well as executed hands-on claims and market access strategy, clinical de- processing and customer service. velopment strategy, patent loss brand retention and sales force optimization.

19 Jenna E. Kerner Melanie W. Kier Susan J. Kim [email protected] [email protected] [email protected] Cornell University, Ithaca, NY Yale University, New Haven, CT University of Maryland, College Park, MD B.A., Summa Cum Laude, Neurobiology B.A., Cum Laude, Economics, 2010 B.S., Information Systems & Marketing, B.A., and Behavior, B.A., Economics, 2011 University of Pennsylvania School of Medicine, Psychology, 2011 Philadelphia, PA M.D. Candidate, 2017

An opportunity to combine my passion An opportunity to combine my clinical An opportunity to combine my technical for experience design and healthcare to and business experiences to improve and business background toward create products at an early stage digital health care delivery. advocating value-based care with a health company. focus on population health to reduce CytomX Therapeutics Inc., costs, increase access and improve Doximity, San Francisco, CA San Francisco, CA quality of healthcare. Product Management Intern, Summer 2016 Clinical Development Intern, Summer 2016 Launched new feature for web prod- Intern to Chief Medical Officer at a Collaborative Health Systems uct to improve customer engagement. biopharmaceutical company focused (Universal American), White Plains, NY Conducted in-depth user interviews to on oncology immunotherapies utiliz- MBA Strategy Intern, Summer 2016 understand customer needs, and ana- ing its novel class of antibody thera- Initiated development of a customized lyzed existing data using SQL to build peutics. Wrote the clinical portion of care management and population case for launch. Conducted research the Investigational New Drug applica- health dashboard prototype alongside for new product, and devised strategy tion submitted to the FDA and wrote a clinical team in integrating disparate for rollout. portions of the phase 1 study protocol. data sources to provide a predictive Created case report forms and ensured analytics tool to monitor beneficiary Lumo Bodytech, Palo Alto, CA data collection documents complied health across 22 MSSP and Next Product Management Intern, Summer 2015 with the protocol and met the needs Generation ACOs. Conducted market Translated user interview findings of the biostatistician. Reviewed research to assess regional ACO into tactical software and hardware clinical site involvement, international and primary care physician group changes, and coordinated with design- regulatory issues, commercial and landscapes and trends within the U.S. ers and engineers to implement priori- shipping requirements, and intellec- tized changes for next 24,000 units. tual property. Deloitte Consulting, Arlington, VA Built company-wide dynamic product Senior Consultant, 2015 roadmap, which became guiding Memorial Sloan Kettering Cancer Center, Consultant, 2013-2014 document for and New York, NY Business Technology Analyst, 2011-2012 company leadership. Implemented Research Study Assistant, 2011-2012 Served healthcare and emerging first-time analytics for iOS and Research Study Assistant in Phase II markets clients within the federal Android, and developed process and Phase III breast cancer therapeutic government on systems integration for monthly measurement. clinical trials sponsored by the National and adoption of new technologies. Cancer Institute. Ensured all study com- Examples include a yearlong modern- Deloitte Consulting, New York, NY ponents and quality checks were met ization application release serving Consultant, 2013-2015 for over 300 patients, i.e. completing 9M+ U.S. citizens/nationals across 250+ Business Analyst, 2011-2013 data entry, organizing patient’s clinic global consulates and an innovative Focused on customer engagement schedules and tests, preparing for data analytics visualization solution to within life sciences industry. Project inspection reviews, conducting radiol- enhance communication and analysis work includes creating a diabetes ogy review and collecting outcomes, across multiple domains. Analyzed wellness program, customer experi- completing regulatory documents, statistical and historical trends to drive ence innovation in oncology, process and submitting documents to the IRB. client decision making in conjunction redesign for R&D shift toward with leading writing efforts on multi- precision medicine and information Goldman Sachs, New York, NY ple contracts and recompetes. management strategy for bioinformat- Summer Analyst, Summer 2009 ics department. Completed projects driven by institutional and hedge fund clients, who generated a variety of requests, such as market updates and analysis. Presented market projections and collaborated with the research team to formulate sales pitches. Culminated in a full-time offer.

20 Jotham H. Klein Michael P. Klein Andrea E. Klestadt [email protected] [email protected] [email protected] University of Pennsylvania, Philadelphia, PA Pomona College, Claremont, CA Yale University, New Haven, CT B.S., Magna Cum Laude, Economics, 2010 B.A., Molecular Biology, 2010 B.A., Magna Cum Laude, with Honors in David Geffen School of Medicine at UCLA, Cognitive Science, 2011 Los Angeles, CA M.D. Candidate, 2018

An opportunity to identify, build and An opportunity to advise and build An opportunity to improve health impact healthcare companies through companies at the crossroads between outcomes and access to care through an equity investment role. healthcare, information technology technological or clinical innovation. and finance. Fred Alger, New York, NY Quartet, New York, NY Research Associate, Summer 2016 Goldman Sachs, San Francisco, CA Operations Intern, Summer 2016 Evaluated public equity securities at Summer Associate, Investment Banking, Identified range of metrics to quantify growth-oriented, $20B mutual fund. Summer 2016 behavioral health provider engage- Conducted fundamental research Conducted financial analyses, due ment and inform incentive contracts; including analysis of value drivers and diligence and M&A-focused materials produced dynamic Excel tool to unit economics, construction of finan- development across 5 clients in the consolidate these metrics and enable cial models, meetings with manage- healthcare and technology industries. field representatives to diagnose and ment teams, interviews with customers Identified precedent financing address engagement issues. Recom- and suppliers, site visits, and industry arrangements, modeled pro forma mended improvements to operational benchmarking. Earned multimillion leverage scenarios and detailed histori- processes, marketing, and product to dollar capital allocation. cal peer expense trends for CFO and increase behavioral health provider board of $2B company. Performed engagement with Quartet based on Apax Partners, New York, NY diabetes devices market review and field research and quantitative analy- Private Equity Associate, 2013-2015 strategic assessment of 25 potential sis. Recruited passionate patient advo- Evaluated investment opportunities acquisition targets. cates for Quartet through developing in healthcare sector for $8B leveraged and executing social media campaign. buyout fund; involved in every aspect UCLA Health, Los Angeles, CA of diligence process, including industry Innovation Intern, Summer 2013 ZS Associates, New York, NY analysis, business quality, synergy Co-authored interview-based “Patient Business Associate Consultant, 2014-2015 potential, and financial assessment. Voice” research framework published Business Associate, 2011-2013 Constructed financial models, led ex- in academic literature, presented to Sales and marketing strategy consul- ternal consultants, identified potential health system executive team and tant for multinational pharmaceutical cost savings, assisted management utilized in UCLA Health’s surgical and biotech companies. Shaped the teams. Board observer to portfolio home and recurring innovation U.S. and global launch strategies of 9 companies. Executed acquisitions of competitions. different products through a combina- One Call ($3.2B) and Genex ($460M). tion of quantitative analyses and qual- Deloitte Consulting, Los Angeles, CA itative market research interviews with Berenson & Co., New York, NY Business Analyst, 2010-2012 over 200 healthcare stakeholders. Investment Banking Analyst, 2010-2013 Worked on 9 team engagements with Developed forecast models for pipe- Advised clients on middle market focus on health system performance line and established drugs. Managed leveraged buyouts, public and private improvement and health care informa- cross-office consulting teams to capital raises, and competed for tion technology. Created industry- optimize clients’ sales force structure, prospective investment banking man- specific surgical services analyses to deployment and targeting. Handled dates on three to five-person teams. identify $25M of annual savings for client communications, led presenta- 10-hospital system. Supported tions and directed workshops. $300M-$1B EHR selection processes and implementation planning, work- ing closely with client IT leadership, for 3 west coast health systems.

21 Aaron D. Kornetzke Elaine Le Craig Limoli [email protected] [email protected] [email protected] The University of Wisconsin, Madison, WI Shanghai International Studies University, Princeton University, Princeton, NJ B.B.A., Finance, 2011 China A.B., Economics, 2012 B.S., Business Economics, 2010

A business development or strategic A strategic or investment role with a Opportunities for my startup, WellSheet, role at a company within the healthcare company across multiple health care which uses analytics to surface key technology space. segments. information for complex patients in an intuitive format. Doximity, San Francisco, CA Warburg Pincus LLP, Shanghai, China Business Development Intern, Summer 2016 Summer Vice President, Health Care Team, WellSheet, New York, NY Sourced and developed partnerships Summer 2016 Co-founder and CEO, 2015-Present in the medical application space and Evaluated 14 public companies across Founded WellSheet while at Wharton. managed Doximity’s API partnership pharma, biotech, device and service Recruited talent from clinical, technical program. Assessed the company’s top sectors, identified two investment and design backgrounds to build out business development opportunities targets and initiated discussion. the team. Earned over $30,000 in and designed a framework through Completed independent industry grant funding from multiple sources, which future growth opportunities analysis and made investment recom- including a federal grant. Oversaw the can be evaluated. mendation for aesthetic medical team building a product that has industry. attracted interest from executives of Procter & Gamble, Cincinnati, OH multiple major health systems, and Financial Analyst – Corporate Strategy, Cathay Capital Private Equity, won recognition from the Office of 2013-2015 Shanghai, China the National Coordinator as one of Financial Analyst – Global Business Services, Associate, 2013-2015 the top innovations for improving the 2011-2013 Analyzed 30+ opportunities in China provider experience. Launched 2 pilots Conducted various industry and and Europe, 80% in healthcare and a distribution partnership with competitive analyses for senior man- industry. Assisted deal sourcing, led established digital health company. agement, including the CEO, CFO and transaction execution, drove cross-bor- Board of Directors. Led a cross-func- der value creation, and successfully International Business Machines, tional team through negotiations with closed five investments with Armonk, NY 3 IT partners, resulting in the establish- aggregated deal size of $145M. Strategy Consultant, 2012-2014 ment of a new IT infrastructure and Senior Strategy Consultant, 2014-2015 service partnership, valued at $75M+ TE Connectivity, Shanghai, China Performed high-profile business analy- over 5 years. M&A Senior Analyst, 2012-2013 sis for executives at IBM headquarters Drove the investment process for a as internal consultant for IBM take-over acquisition that bridged a Corporate Strategy to segment and major product gap. Developed a $30M evaluate the consulting business unit. growth plan for Medical business unit Managed 8 person team performing by analyzing market and competitive an assessment of a network of mental dynamics, prioritized growth opportu- health providers across a set of clinical, nities and created implementation business, and technology parameters. plan. Led large, multifunctional team, coor- dinating with healthcare providers, A.T. Kearney , IBM experts, and client clinical team to Shanghai, China implement Electronic Medical Record Business Analyst, 2010-2011 integration. Top performer within rank. Advised financial investor clients on commer- cial due diligence on retail chains and telecom devices to evaluate market potential and risk. Advised clients develop new product strategy, supply chain optimization and operation efficiency improvement.

22 Ravi A. Mahadevia Eriko Matsumoto Matthew G. [email protected] [email protected] McLaughlin Northwestern University, Evanston, IL Keio University, , Japan B.A., Psychology, 2008 B.A., Business and Commerce, 2007 matthew.mclaughlin.wg17@ wharton.upenn.edu Stanford University, Palo Alto, CA B.A., Political Science, 2008

An opportunity to build leading health A project management opportunity to An opportunity to build a company that care services companies through invest in health systems and create empowers consumers to make more management or investment. health system models to improve informed decisions about their health. quality and cost effective management. Somnium Sleep Solutions, New York, NY Lazard, Los Angeles, CA Founder & CEO, 2012-Present UAB Health System, Birmingham, AL MBA Associate, Summer 2016 Developed unique sleep center Administrative Fellow, Summer 2016 Co-developed marketing materials for management contract business model, Created a strategic plan and analyzed the divestiture of a ~$200M revenue researching market interest and opera- effectiveness of Access Center division of a space technology busi- tional feasibility across the country to to improve room utilization for ness. Managed the sell-side diligence establish Somnium and open diagnos- Neurology clinic and patients’ process for a regional ethnic food tic sleep centers to treat sleep apnea accessibility. Attended leadership manufacturer (TEV ~$300M). by partnering with physician-owned meetings to propose ideas on room surgical hospitals. Led set-up of all for improvement. Kingfish Group, Foster City, CA sleep centers by managing every part Principal, 2013–2015 of the process: hiring employees, MC Healthcare, Inc., Tokyo, Japan Built the company’s healthcare training staff, integrating sleep center Senior Manager, Sales and Marketing independent sponsor capabilities by within the hospital, accounting, and Department, 2012-2015 developing relationships with ~180 obtaining insurance contracts, Unit Manager, Pharmaceutical Products Unit, high-profile healthcare executives. resulting in four centers that generate 2011-2012 Generated 68 actionable investment over $1.5M in revenue annually. Led 6 sales people and responsible for opportunities, 6 of which were propri- total sales activities to implement etary. Collaborated with sponsors on Lincoln International, Chicago, IL supply chain management. Achieved an $80M investment in a psychological M&A Healthcare Investment Banking a large-scale order intake in 2013 of services provider. Analyst, 2010-2012 $15 million of medical supplies for a Conducted due diligence, drafted deal flagship hospital. Led Pharmaceutical Oliver Wyman, San Francisco, CA process materials, ran LBO and DCF Products Committee for GPO; Senior Consultant, 2012-2013 valuations, and completed other M&A Succeeded in negotiation with drug Consultant, 2010-2012 activities, resulting in seven closed manufacturers and reshaped previous Advised global and U.S. clients on transactions that totaled over $750M business model into new business a range of operational initiatives. in valuations over two years. model first time ever in Japan. Notably, for a major U.S. residential supply manufacturer, evaluated Deloitte Consulting, Chicago, IL Mitsubishi Corporation, Tokyo, Japan ~$96M in finished goods inventory Strategy & Operations Business Analyst / Consultant/Sub-Project Manager, Healthcare and developed recommendations Consultant, 2008-2010 Business Department, 2007-Present to reduce inventory by ~$22M. Consultant in the health care services Led proposal-based hospital construc- and insurance sectors. Project exam- tion, maintenance and management Stanford Student Enterprises, ples include creating a new channel projects. Won a PFI tender for Kyoto Stanford, CA strategy for a payer’s exclusive / inde- City Hospital ($0.9B in total, 18-year CEO, 2008-2010 pendent agent force and implement- contract); Pioneered a plan for cost Managed a ~$1.8M revenue business ing cost reduction strategies for a benchmarking for medical supplies with 50+ employees. Launched SSE large health care services business. and pharmaceuticals procurement that Labs (now StartX) — a seed accelerator achieved a cost reduction of 5% in the supporting student entrepreneurs. very first year of its implementation. Since its inception, the program has graduated 100+ companies, which have raised over $400M in funding.

23 David E. Mishkin Marcus S. Moreno Ryan J. Mullaney [email protected] [email protected] [email protected] Washington University, St. Louis, MO Harvard University, Cambridge, MA Boston College, Chestnut Hill, MA B.S., Finance, 2009 A.B., Economics, 2008 B.S., Cum Laude, Finance, 2011

An opportunity to operate and invest An opportunity to improve care delivery An opportunity to build, and invest in innovative healthcare services and and reshape the patient experience. in, businesses focused on developing technology companies. curative therapies for rare diseases. Rezilir Health, Boca Raton, FL Oak HC/FT, Greenwich, CT Director of Product Development, InTandem Capital Partners, MBA Intern, Summer 2016 Summer 2016 New York, NY Formulated investment thesis and Designed beta version of the compa- Summer Investment Professional, sourced potential investments in the ny’s first product — patient-centric Summer 2016 health insurance space. Conducted due health and wellness packages — to Worked directly with Managing diligence, including thorough valua- make living healthy simple. Developed Partner and InTandem team in fund- tion, operational, financial, legal and market entry and pricing strategy raising efforts by crafting LP presenta- regulatory review of companies in the based on market segmentation and tions, attending LP meetings, and in pharmacy and network management competitive landscape assessment. fulfilling LP requests. Supported live sectors. Curated list of 100+ potential partner transactional efforts in health care communities resulting in first commu- services vertical by managing due- Sandbox Industries, Chicago, IL nity partnership. diligence processes, building compre- Vice President, 2014-2015 hensive financial model and valuation Associate, 2013-2014 CVS Health, Northbrook, IL materials, and working with lender Analyst, 2012-2013 Product Innovation Senior Advisor, partners. Managed a $325M venture fund in- 2014-2015 vesting in seed through growth equity Product Innovation Advisor, 2012-2013 Riverside Partners, Boston, MA stage healthcare and technology com- Developed and led initiative to expand Private Equity Associate, 2013-2015 panies. Prospected and sourced over the product pipeline; engaged cross- Analyzed 30+ investment opportuni- 250 new investment opportunities. functional team of 35 resulting in 6 ties in healthcare and technology sec- Engaged in every aspect of the invest- product concepts to be prototyped tors. Managed transaction execution ment process, participating in 8 new and tested. Embedded new innovation process including financial and opera- and follow on financings. Actively capabilities by facilitating workshops tional due diligence, market and in- supported 6 portfolio companies by to train more than 100 colleagues and dustry analyses, valuation and returns attending board meetings; assisted clients in innovation processes. Led analyses, and deal structuring and with financial planning, development, team developing enterprise strategy legal documents. Closed two add-on recruiting, and sales; generated $55M options to reduce total client phar- investments with aggregate deal size in sales contracts between our macy costs and grow enterprise share. of $35M. Successfully exited invest- portfolio companies and our health ment in portfolio company. plan investors. Rezilir Health, Weston, MA Consultant, 2011-2012 J.P. Morgan, New York, NY Barclays Capital, New York, NY Senior Analyst, 2009-2011 Investment Banking Analyst, 2011-2013 Investment Banking Analyst, 2010-2012 Analyst, 2008-2009 Analyzed mergers, acquisitions, Executed financial models to assess Led life sciences projects focused on divestitures, equity and debt capital M&A transactions and capital structure developing go-to-market strategies, raises, and other strategic alternatives. alternatives. product portfolio optimization, and Managed junior deal teams across due diligence. Performed as team multiple product groups on $5B+ of leader designing analyses and research completed equity and debt transac- instruments, developing dynamic mod- tions, and sell-side M&A transaction. els, conducting interviews and surveys, Ranked in top quartile for all perfor- and coordinating day-to-day activities. mance reviews; received third-year analyst offer.

24 Daniel G. Mulreany Andrew R. Neill Vinayak S. Nikam [email protected] [email protected] [email protected] Johns Hopkins University, , MD Texas Christian University, Fort Worth, TX Duke University, Durham, NC B.S., Biomedical Engineering, B.B.A, Finance, 2008 B.S., Biology with Honors, History, 2012 Electrical Engineering, 2005 Perelman School of Medicine at the University M.S.E., Biomedical Engineering, 2010 of Pennsylvania, Philadelphia, PA M.D. Candidate, 2017

An opportunity to work in the An opportunity to invest in and/or An opportunity to bring life-changing biotechnology industry, at the launch and develop early-stage biophar- therapies to the patients who need intersection of science and business. maceutical companies developing novel them. therapeutics for completely unmet Amgen, Thousand Oaks, CA medical needs. SR One, Ltd., San Francisco, CA Intern, Business Development, Summer 2016 Summer Associate, Summer 2016 Developed new evaluation methodol- Lumos Pharma, Austin, TX Evaluated investment opportunities ogy for device and digital health tech- Corporate Development, Summer 2016 for a life sciences-focused venture cap- nologies in support of CEO strategic Further developed and implemented ital firm. Assisted in the daily opera- initiative to improve competitiveness corporate strategies, including future tions of a biotech start-up undergoing and patient experience. financing and patient diagnosis and incubation by the firm. Conducted acquisition strategies. Assisted in the four therapeutic area assessments for Corporate Executive Board, preparation of Investigational New an oncology start-up in the firm’s in- Washington, DC Drug Application. Currently manage vestment portfolio. Senior Analyst, Corporate Strategy & budget process in an on-going Development, 2014-2015 manner, among other duties. Regeneron Pharmaceuticals, Inc., Senior Research Analyst, 2013-2014 Tarrytown, NY Designed and implemented a Lumos Pharma, Austin, TX Business Development Intern, Summer 2016 firm-wide strategic planning process, Co-Founder, Business and Corporate Investigated scientific and commercial achieving coordination following Development, 2011-2015 rationale for expansion of pipeline a major acquisition. Evolved global Identified and in-licensed a novel antibodies to additional therapeutic partnership strategy, advancing treatment for the rare disease Creatine areas in oncology. Directed team of CEB’s position in global markets Transporter Deficiency. Raised $14M clinical, manufacturing and financial on 6 continents. Series A from New Enterprise personnel to evaluate strategic part- Associates, Santé Ventures, and UCB. nership opportunities in industrial Human Genome Sciences, Rockville, MD Company has since raised a $34M operations. Conducted due diligence Image Analyst, Immunology and Oncology Series B. Developed and managed pro on three strategic partners to inform Research Departments, 2011-2012 forma financials. Secured key collabo- potential deal negotiations and Led implementation of $500,000 rations with the National Institutes of partnerships in inflammation and investment in pre-clinical imaging, Health’s Therapeutics for Rare and pain space. accelerating development of 12+ new Neglected Diseases Program and the drug candidates. Produced integral UK’s Wellcome Trust. Developed com- Zeno Pharmaceuticals, , CA data for two Investigational New Drug mercial model, including epidemiology Strategy Intern, 2015-2016 applications. Won company-wide and market assessments. Managed Performed market landscape analysis competition for project visualizing hiring of key personnel and aspects of of multiple oncology therapeutic areas drug efficacy. non-clinical and clinical development for two novel small molecule inhibi- plan. Interfaced directly with Board tors. Identified and analyzed potential Johns Hopkins University, Baltimore, MD of Directors. partners to fund continued research Research Biomedical Engineer, 2005-2008 and development. Utilized novel biomedical imaging Innovations in Drug Development (id2), techniques to advance understanding Austin, TX and treatment of lung disease. Analyst, 2009-2015 Authored 6 publications in high- Conducted due diligence on prospec- impact journals. Designed new tive investment opportunities in the ventilator control system, enabling life sciences and healthcare industries. experiments that verified a key hypoth esis in lung disease manage- ment.

25 Norman L. Pai Jordan M. Pecherer Margot D. [email protected] [email protected] Prendergast Rice University, Houston, TX University of Michigan, Ann Arbor, MI B.S., Cum Laude, Electrical Engineering, 2011 B.S., Biochemistry, 2010 margot.prendergast.wg17@ wharton.upenn.edu Boston College, Chestnut Hill, MA B.S., Magna Cum Laude, Finance, 2009

An opportunity to leverage my technol- An opportunity to build leading health- An opportunity to bridge the gap ogy and analytics experiences to im- care businesses through investment or between corporate and non-profit prove healthcare data applications. management. global health delivery.

HealthVerity, Philadelphia, PA J.P. Morgan Chase, San Francisco, CA Novartis, East Hanover, NJ Product Manager, Summer 2016 Summer Associate, Healthcare Investment MBA Associate, Finance Development Led a team of 4 engineers to complete Banking, Summer 2016 Program, Summer 2016 3 product roadmap milestones on time Contributed to execution of a large- Worked as a member of the U.S. including Marketplace platform cap biotech M&A transaction follow- General Medicines business unit launch. Bridged communication gaps ing activist defense. Conducted finance team; analyzed brand perfor- across founders, analytics & engineer- financial analysis and process support mance drivers and generated new KPI ing. Transformed development from for debt and equity financing transac- reports, developed and tested demand Kanban to Scrum process. Hosted 9 UI/ tions for mid- to small-cap biotechnol- forecasting models, and supported UX and technical design sessions yield- ogy and medical device companies. annual budget process. ing new data models and user flows. IndUS Growth Partners, Boston, MA Partners In Health, Neno, Malawi Slalom Consulting, San Francisco, CA Private Equity Associate, 2015 Program and Operations Coordinator, Information Management and Analytics Led proactive sourcing, evaluation and Global Health Corps Fellow, 2014-2015 Consultant, 2013-2015 proposed deal structuring for prospec- Selected for one of 128 Global Health Created and steered internal Data tive acquisitions and led post-merger Corps fellowship positions from appli- Science group. Supported $1.5M+ of integration and portfolio company cant pool of nearly 5000 candidates. advanced analytics engagements. Built strategy for completed acquisitions Implemented new inventory manage- predictive models to improve generic for private equity firm with $2B under ment system supporting district drug launch accuracy by 4X. For management. Executed transactions hospital in rural, resource poor various clients, produced Tableau-R in the healthcare data and analytics environment. Drove logistics and dashboards, developed data ware- (Activate Networks) and hospital purchasing to rapidly scale disaster houses, and conducted data analysis market research (Healthcare Business response following historic flooding affecting management decisions. Insights) sectors. and declaration of natural disaster.

Accenture, San Francisco, CA Decision Resources Group, Partners HealthCare System, Boston, MA Business Intelligence (BI) Consultant, Burlington, MA Business Analyst, Partners HealthCare 2012-2013 Consultant, 2012-2015 International, 2012-2014 Innovation Centers for SAP Solutions & Consultant to the biopharmaceutical Contract Data Analyst, 2010-2012 Mobile Technology Analyst, 2011-2012 and medical device industries. Delivered analytical support to drive Designed and deployed Accenture Contributed to and led teams through international business development iPad app to App Store: as product over 30 engagements focused on initiatives, including investment owner and content creator, shaped assessing the commercial opportunity in international referral channels. director’s idea into cross-industry for pharmaceutical and medical device Supported hospital supply chain showcase used by 500+ executives products in both emerging and devel- management through contract data worldwide. Made 2 interactive iPad oped markets. Engagements focused analytics. app prototypes, architected 15+ on market opportunity assessments, decision tools for Fortune 500 clients revenue forecasting, clinical trial strat- and reduced data analysis time by egy, regulatory and reimbursement over 95%. strategy, and licensing and acquisition strategy.

26 Michael Rahman Jon Michael Reese Steven F. Rizzo [email protected] [email protected] [email protected] St. Olaf College, Northfield, MN Vanderbilt University, Nashville, TN Cornell University, Ithaca, NY B.S., Cum Laude, Economics and Psychology, B.A., Economics, 2010 B.S., Cum Laude, Applied Economics 2012 & Management, 2010 Level III CFA Candidate

An opportunity to work on a dynamic An opportunity to identify, build An opportunity to work with a dynamic team within health care services or IT, and direct market-leading healthcare team to develop and execute strategy with responsibility for strategic finance companies through an equity for health care companies. and other operational initiatives. investment role. Deloitte Consulting, Philadelphia, PA Brighton Health Plan Solutions, Citadel, New York, NY Strategy & Operations Summer Associate, New York, NY Surveyor Capital Summer Associate, Summer 2016 Intern, Summer 2016 Summer 2016 Advised on a corporate strategy re- Worked with the CEO of Brighton Initiated long / short equity coverage fresh for a Fortune 500 pharmaceutical Health Plan Solutions and led initia- of subsectors within healthcare, company. Designed survey instruments tives across strategic finance, business transportation and business services. to identify and prioritize key corporate development, network strategy and Completed business diligence and pre- strategy initiatives. Moderated inter- cost containment operations. sented investment recommendations views with Deloitte leaders on analyt- Presented 2016 budget, five-year resulting in portfolio investments. ics best practices; synthesized and financial forecast and unit economics Accurately predicted EPS and direc- shared learnings that informed to the Board of Directors and achieved tional share price movement for the restructuring of the client’s 300 financing to support newly launching two companies in coverage space that person, $250M internal analytics company. Led contract negotiation reported quarterly earnings. group. and implementation with an out-of- network cost containment vendor. GTCR, Chicago, IL Navinata Health, Princeton, NJ Senior Associate, 2014-2015 Director of Operations, 2015 UnitedHealth Group, Minnetonka, MN Associate, 2012-2014 Collaborated on the design and devel- M&A Associate, 2012-2015 Originated and led private equity opment of the company’s first technol- Corporate M&A team reporting to transactions across 4 platforms in ogy offering — an online platform the CFO of UnitedHealth Group, healthcare industry including invest- enabling information exchange & edu- responsible for acquisitions at ments in outsourced contract steriliza- cation between Pharmaceutical com- UnitedHealthcare and Optum. Worked tion (Sterigenics International), life panies and Physicians. Negotiated the with senior executives to forecast sciences tools and diagnostics (Cole- selection of multiple partners related target company financials, conducted Parmer Instruments), healthcare ser- to website design, data visualization valuation analysis and assessed finan- vices to correctional institutions (CHC), and survey development, key compo- cial returns of potential acquisitions. and independent pharmacy software nents for the creation of the platform. Collaborated with executives to coor- (Rx30) sectors. Identified attractive dinate due diligence and evaluate segments within healthcare industry, ZS Associates, Princeton, NJ strategic fit, synergies and integration analyzed market characteristics, Associate Consultant, 2013-2015 costs. constructed detailed financial models, Business Associate, 2010-2012 directed due diligence efforts, and Sales and Marketing strategy consult- participated in board meetings. ing for pharmaceutical and biotech firms, with an emphasis on oncology Bank of America Merrill Lynch, and cardiovascular disease. Managed New York, NY client relationships and led cross-func- Analyst, 2010-2012 tional teams in qualitative and quanti- Completed 43 high yield bond and tative market strategy projects. leveraged loan offerings with total Designed research instruments and an- aggregate value of over $24B to sup- alytical methods to inform commercial port leveraged buyouts, recapitaliza- strategy. tions, and refinancings.

27 Riddhi Roy Viba Saligrama Barthalomew A. [email protected] [email protected] Sillah Carnegie Mellon University, Pittsburgh, PA Georgetown University, Washington, DC B.S., M.S., with University Honors, Chemistry, B.S., Summa Cum Laude, Business [email protected] 2010 Administration, 2011 Harvard University, Cambridge, MA A.B., Human Developmental and Regenerative Biology, 2012 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M.D. Candidate, 2017

An opportunity to impact patients An opportunity in strategy or An opportunity to combine my clinical through a commercial strategy role operations to improve value in health training and business experience to in a life sciences company. care delivery and focus on wellness improve health systems management and prevention. and business development. Genentech, South San Francisco, CA Commercial Intern in Pricing, Contracting, DaVita Healthcare Partners, Denver, CO University of Pennsylvania Health and Distribution, Summer 2016 Redwoods Summer Associate, Summer 2016 System, Philadelphia, PA Led assessment of specialty drug distri- Led a project exploring impact of Administrative Fellow, Summer 2016 bution centers for infused products. patient experience on clinical and Structured partnerships and medica- Analyzed risks and developed strategic business outcomes for primary care tion dispensing agreements with key recommendations around how to treat practices. Conducted 40 interviews pharmaceutical companies increasing distribution centers, pre- and post-bio- and reviewed secondary research to department revenue by $26M. similar launch. Presented recommen- develop framework. Analyzed patient Directed a lean transformation dations to functional leadership. satisfaction survey data from 100+ initiative to increase patient flow clinics to identify correlations between in the outpatient oncology clinic. Deloitte Consulting, Pittsburgh, PA survey results and key performance Consultant, 2013-2015 metrics, including hospital utilization Excelsior Group, Nairobi, Kenya Business Analyst, 2011-2013 and member growth rates. Provided Fellow, Summer 2015 Gained experience with health plan, recommendations to improve patient Conducted investment due diligence provider, and life sciences sectors. experience and inform future invest- of private pharmaceutical, medical Focused on pharmaceutical and ments. devices and health services companies. biotech industry, worked on projects Advised a portfolio company in key ranging from R&D operations to Deloitte Consulting, Washington, DC strategic decisions and business model commercial strategy. Performed R&D Consultant, 2013-2015 redevelopment. spend benchmarking assessment Analyst, 2011-2013 for global pharmaceutical company Strategy and operations consultant King’s Sierra Leone Partnership, through peer company interviews for U.S. government healthcare agency Freetown, Sierra Leone to inform annual R&D budget. clients. Project work included strategic Hospital Administration Intern, Summer and Coordinated relaunch activities for planning, resource allocation, program Fall 2013 two acquired assets and conducted evaluation and process improvement. Developed and implemented a survey workshop to determine long-term Developed Defense Health Agency’s tool to integrate patient feedback into therapeutic area portfolio strategy. long-term prevention strategy and administrative operation decisions. managed the design, marketing and Performed a lean transformation Quality of Life Technology Foundry, implementation of 5 public-health with the billing and collections office Pittsburgh, PA pilot projects on nine military bases. increasing bed turnover by 15%. Foundry Associate, 2010-2011 Analyzed 10 business plans to support Identified hygiene education methods Developed and presented business an ACA financing program. Designed a that helped decrease hospital acquired plans to investors for research prioritization process to better allocate infection rates by 24%. enabling people with disabilities to $1B budget spent on food safety. live independently. Organized all Reviewed proposals to improve logistics and content for company Veteran health and built data man- booth at Consumer Electronics Show, agement tools to support budgeting managed $100K budget, and made decisions. connections to future investors. Managed summer interns and sup- ported annual report development.

28 Christopher J. Skayne George H. Stein William P. Stratton [email protected] [email protected] [email protected] Amherst College, Amherst, MA University of Pennsylvania, Philadelphia, PA Yale University, New Haven, CT B.A., Law, Jurisprudence, and B.A., Magna Cum Laude, Economics and B.S., Intensive Major, Chemistry, 2011 Social Thought, 2011 East Asian Studies, 2010

To improve the delivery and financing An opportunity to build innovative An opportunity to help grow an of health care services. health care services and digital health innovative biopharmaceutical company companies that change care delivery. through business development or McKinsey & Co., , MI commercial strategy. Summer Associate, Summer 2016 UnitedHealth Group Ventures, Advised leading health care company Minnetonka, MN Cidara Therapeutics, San Diego, CA on the creation of a health care Summer Associate, Summer 2016 Business Development and Marketing Intern, services subsidiary. Created strategic Gained exposure to group’s venture Summer 2016 vision documents, counseled on buy vs. capital investment processes by Examined potential M&A candidates build decision for a new technology, supporting two pipeline projects and based on therapeutic and strategic and developed long-term financial working extensively with portfolio alignment with Cidara’s development forecasting tool. company. Identified 50% revenue programs. Assessed the potential for opportunity at start-up in portfolio an alternative route of administration athenahealth, Watertown, MA by stratifying sales prospects, creating for Cidara’s lead candidate (CD101) Senior Associate Corporate Strategy, consistent processes and developing and delivered a strategic plan for the 2013-2015 distinct customer segments and program. Analyzed the addressable Senior Associate Business Development, quantifying customer lifetime value market and commercial opportunities 2012-2013 of each segment. for new indications for CD101, provid- Conducted due diligence and executed ing recommendations on attractive acquisition of publicly traded McKinsey & Company, Washington, DC indications, clinical development Epocrates, Inc. – developer of most Senior Business Analyst, 2014-2015 considerations, and lifecycle manage- used mobile app in health care – for Business Analyst, 2012-2014 ment strategies. $307M. Managed post-acquisition in- Focused time on technology, strategy, tegration work streams; presented to and operations primarily for health The Amundsen Group, an IMS Health athenahealth CFO the achievement of care and TMT clients. Developed and Company, Burlington, MA $10M+ in cost-savings synergies. Led built business cases and models for >20 Consultant, 2014-2015 a revamp of business’s Customer new B2B / B2C products. Created Associate Consultant, 2013-2014 Relationship Management system to strategy for developing private ex- Provided data analytics and strategic increase efficiency and give manage- change offering. Identified ~$70M in insights to biopharmaceutical clients. ment visibility into the $100M+ sales opportunities for health care client as Managed project teams on various pipeline. Developed commercial turn- part of organizational transformation. engagements, including market land- around strategy for business unit’s free Designed software reduction program scape assessment, payer control and mobile application; led launch of new to achieve savings for EMR business contracting strategy, primary market ad-unit to successfully drive renewed case. research, and launch planning. sales momentum. The Advisory Board Company, The Exeter Group, Boston, MA Cambridge Associates, Boston, MA Washington, DC Consultant, 2011-2013 Consulting Associate, 2012 Senior Analyst, 2011-2012 Project manager at a national, Worked across teams of consultants, Analyst, 2010-2011 non-profit blood bank. Supported specialists, and investment analysts on Developed strategic and operational the planning and implementation of a nine unique client teams, conducting expertise — primarily in health IT, phy- new software system to update blood analyses, tailoring investment recom- sician topics (engagement, leadership labeling and manufacturing processes. mendations, and presenting findings and hospital-physician contracts) and Managed over 150 people delivering to university and museum investment care management—related to health over 1,300 documents used to train boards. care transformation for providers. staff on new processes.

29 Michael L. Suiters Fiona Tang Alex Wittenberg [email protected] [email protected] [email protected] Davidson College, Davidson, NC University of Michigan, Ann Arbor, MI Stanford University, Palo Alto, CA B.A., History, 2010 B.S., With Distinction, Economics and B.A. with Distinction, Phi Beta Kappa, Mathematics, 2011 International Relations, 2012

An opportunity to build transforma- An opportunity to work on or build An opportunity in impact investing or tional healthcare technology and elder care services in China. general management with a company services companies as an operator focused on products or services that or investor. Goldman Sachs, Hong Kong, China improve global health. Summer Associate, Summer 2016 Oxeon Ventures, New York, NY Worked on a variety of projects to The Global Health Investment Fund, Summer Senior Associate, Summer 2016 provide financial advisory to Chinese New York, NY Co-wrote the business plan for spin- clients ranging from IPO, private Summer Associate, Summer 2016 ning out technology developed within placement and M&A. Led diligence on a novel therapeutic a leading $6B Integrated Delivery for soil-transmitted helminthiases, Network (IDN) into an independent Capital One, Wilmington, DE evaluating the financial upside, global start-up. Led financial feasibility and Senior Analyst, 2013-2015 health impact, and technical and competitive analyses and presented Built and executed marketing and regulatory risks of financing the drug’s recommendations to IDN leadership product strategies for Capital One 360. development and commercialization. en route to a “green light” funding Created impact model quantifying the decision. Supported Oxeon’s first McKinsey & Company, Pittsburgh, PA number of lives saved and improved limited partner fundraise including the Business Analyst, 2011-2013 from existing investments in diagnos- economic analysis of venture capital Provided strategy consulting services tics, drugs, and vaccines. fund structures and development of to providers, payors and pharmaceuti- limited partner recruitment materials. cal companies on healthcare reform Bain & Company, Los Angeles, CA strategy, organization restructure, Senior Associate Consultant, 2014-2015 Evolent Health, Arlington, VA acquisition strategies and etc. Associate Consultant, 2012-2014 Director, Strategy 2015 Strategy consultant across sectors Associate Director, 2013-2014 including private equity, media & Senior Analyst, 2012 entertainment, and biotechnology. Accelerated Evolent Health’s growth Biotechnology projects spanned from Series A to $1B+ IPO while shared services design & organiza- contributing cross-functionally across tional strategy and process mapping corporate strategy, sales, finance, and optimization. and operations. Most recently advised senior management on the value The Bill & Melinda Gates Foundation, and relative prioritization of growth Seattle, Washington initiatives including new product Strategy Consultant, 2014-2015 development, new market entry, and (on externship from Bain & Company) acquisitions, and partnered with senior Coordinated working team of six executives to rollout initiatives. scientists and led strategic initiatives for a new program investing in inno- Deloitte Consulting, Washington, DC vations to treat preterm birth, growth Consultant, 2012 stunting, and neurocognitive deficits Analyst, 2010-2012 in developing countries. Organized Analyzed implications of healthcare and facilitated budgeting sessions to reform for clients and the Deloitte allocate $150M to global health clini- Center for Health Solutions. cal trials and technology development.

30 Christina M. Wray Amanda B. Wyatt Linan Xiao [email protected] [email protected] [email protected] Dartmouth College, Hanover, NH Harvard College, Cambridge, MA Duke University, Durham, NC B.A., Magna Cum Laude, Biology with A.B., Cum Laude, Social and Cognitive B.S., Biology, 2009 High Honors, 2012 Neuroscience, 2012 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M.D. Candidate, 2017

An opportunity to promote medical An opportunity to grow innovative life An opportunity to improve quality, device innovation and the commercial- sciences products and impact patients value and access to cutting edge ization of new surgical technologies. through a marketing role in the healthcare innovations. biopharmaceutical industry. Action Potential Venture Capital, Amgen, Thousand Oaks, CA Palo Alto, CA Pfizer, New York, NY Commercial Leadership Program, MBA Summer Associate, Summer 2016 Marketing MBA Summer Associate, Summer 2016 Evaluated investment opportunities Summer 2016 Spearheaded launch preparations for and conducted investment diligence Spearheaded national educational new indication of in-line hematology on companies in the bioelectronic program with 50 sessions for health drug. Reassessed commercial opportu- medicine space. Conducted a market care professionals in advance of high- nity and conducted customer research overview to evaluate promising novel profile label update; worked closely to identify patient segments, clinical therapies in a specific disease area. with medical, regulatory, and legal unmet needs and opportunities. Worked directly with a portfolio colleagues to develop content at risk, Determined product positioning and company to design a study to inform a first for the division. Conducted core value messages by interfacing product design specifications. analysis on reach and engagement with clinical trial leaders, customers of previous programs, ultimately and sales team. Recommended University of Pennsylvania Department recommending new program format optimal sales force & non-personal of Otolaryngology, Philadelphia, PA to maximize ROI adopted by the tactics based on ROI analysis. Research Assistant, 2014-2016 team lead. Conducted a literature review on IMS Consulting Group, New York, NY clinical outcomes and quality of life TribalVision, Boston, MA Consultant, 2014-2015 following a novel treatment for Project Leader, 2014-2015 Associate, 2012-2014 obstructive sleep apnea. Evaluated the Consultant, 2013-2014 Analyst, 2010-2012 effect of commercial thickening agents Associate, 2012-2013 Market access and commercial strategy on the perceived palatability of Marketing and strategy consultant for consultant for pharmaceutical, biotech liquids. Documented the first-ever midsized firms, including medical and medical device companies. report of a hypopharyngeal malig- device manufacturers, health centers, Managed teams of associates in nancy arising in a field of Crohn’s and technology service providers. As a conducting qualitative and quantita- disease. Project Leader, concurrently managed tive engagements, to provide recom- 4-6 client accounts, domestic and inter- mendations to sales and marketing national, with 6 direct reports. Built a executives in U.S., E.U. and global new e-commerce solution for a U.S. emerging markets. Created and device manufacturer; increased online launched global and local pricing sales by 18% and order volume by strategies; other project experience 14%. Designed ACA communications spans clinical development, value strategy for a non-profit health center, messaging, life cycle management, helping to educate and ultimately en- launch excellence, health economics roll 1300 formerly uninsured patients. and policy advocacy. Completed market entry strategy for Korean device manufacturer, evaluating $1.2 billion U.S. market opportunity.

31 Jaeyoung Yang [email protected] Yale College, New Haven, CT B.A., Economics and International Studies, 2009 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M.D. Candidate, 2017

A clinical and strategy role with a health services company focused on innovative care models.

Iora Health, Boston, MA Summer Associate, Summer 2016 Developed referral management pro- gram for a national chain of primary care clinics with emphasis on clinical follow-up, user experience, and operational efficiency. Established five market-based call centers for 43 staff to support $3M patient recruitment effort.

Office of Clinical Effectiveness and Quality Improvement, University of Pennsylvania Health System, Philadelphia, PA Summer Intern, Summer 2013 Spearheaded successful interdepart- mental project to reduce length-of- stay for a high-volume surgery by identifying key variations in post-op care in a comparative hospital study and implementing a ‘fast-track’ pathway (est. $100,000/year saved).

The Camden Coalition of Healthcare Providers, Camden, NJ Assistant Project Manager, 2011-2012 Successfully applied for $300,000 in grants for seven staff positions in care coordination. Established “health coach” program by negotiating with AmeriCorps and local providers to share oversight and funding. Recruited 5 members, led training/onboarding process, and oversaw operations. Facilitated multi-stakeholder working group to promote primary care in a 400-unit low-income housing complex.

32 2016 Internship Sponsors

The following organizations FRAZIER HEALTHCARE PARTNERS OXEON VENTURES provided internships for Health Care Seattle, WA New York, NY Management Students in Summer, 2016. FRED ALGER PFIZER New York, NY New York, NY

GENENTECH QUARTET HEALTH South San Francisco, CA New York, NY ACCOLADE Plymouth Meeting, PA GENEOSCOPY REGENERON PHARMACEUTICALS St. Louis, MO Tarrytown, NY ACTION POTENTIAL VENTURE CAPITAL Palo Alto, CA THE GLOBAL HEALTH INVESTMENT FUND REZILIR HEALTH New York, NY Boca Raton, FL ALEDADE Bethesda, MD GOLDMAN SACHS RITTENHOUSE VENTURES San Francisco, CA Philadelphia, PA AMGEN Hong Kong, China Thousand Oaks, CA SEATTLE GENETICS HEALTHVERITY Seattle, WA ATHENAHEALTH Philadelphia, PA Watertown, MA SOMNIUM SLEEP SOLUTIONS IBM New York, NY BAIN & COMPANY Austin, TX Dallas, TX SR ONE LTD. INTANDEM CAPITAL PARTNERS San Francisco, CA BANK OF AMERICA New York, NY Cambridge, MA New York, NY IORA HEALTH TAKEDA PHARMACEUTICAL COMPANY BRIGHTON HEALTH PLAN SOLUTIONS Boston, MA Deerfield, IL New York, NY J.P. MORGAN CHASE TELADOC CIDARA THERAPEUTICS San Francisco, CA Purchase, NY San Diego, CA LAZARD UAB HEALTH SYSTEM CIGNA Los Angeles, CA Birmingham, AL Philadelphia, PA LEK CONSULTING UNITEDHEALTHCARE CITADEL Los Angeles, CA Minnetonka, MN New York, NY LUMOS PHARMA UNITEDHEALTH GROUP VENTURES CLINTON HEALTH ACCESS INITIATIVE Austin, TX Minnetonka, MN Phnom Penh, Cambodia MCKINSEY & COMPANY UNIVERSITY OF PENNSYLVANIA CLOVER HEALTH Palo Alto, CA HEALTH SYSTEM Jersey City, NJ Denver, CO Philadelphia, PA Chicago, IL COLLABORATIVE HEALTH SYSTEMS Detroit, MI VENTUS HEALTH INVESTORS (UNIVERSAL AMERICAN) Summit, NJ Philadelphia, PA White Plains, NY New York, NY WARBURG PINCUS, LLP COMMUNITY VETERINARY PARTNERS MEDTRONIC Shanghai, China Philadelphia, PA Santa Rosa, CA Minneapolis, MN WELLSHEET CYTOMX THERAPEUTICS New York, NY San Francisco, CA NEW CAPITAL PARTNERS Philadelphia, PA WELLTHIE DAVITA HEALTHCARE PARTNERS New York, NY Denver, CO NOVARTIS East Hanover, NJ WELLTOK DELOITTE CONSULTING Basel, Switzerland Newport Beach, CA Philadelphia, PA NUNA HEALTH DOXIMITY San Francisco, CA San Francisco, CA OAK HC/FT Greenwich, CT

33 2016 Health Care Program Mentors

Mentors are leaders and senior managers ALI BEHBAHANI, MD CHRISTOPHER P. CHEN, MD in the healthcare field who have agreed to Partner Associate; Hospitalist at UW New Enterprise Associates McKinsey; University of Washington provide career and professional development Chevy Chase, MD Medical Center advice and guidance to Health Care Seattle, WA ERIC R. BELL Management Students. Managing Director EMILIE COUEIGNOUX CHEN SpringRock Ventures Senior Manager, Market Planning Seattle, WA Seattle Genetics Bothell, WA SIGAL BEN-ARI, PHD ABHISHEK AGRAWAL COO MARK CHIN Associate Director, Marketing Kodu Care Investment Manager Merck Sharpe & Dohme, India Seattle, WA Arix Bioscience Mumbai, India New York, NY RYAN BERGER EUGENE AN Senior Business Strategist AMY CHIU Group Product Manager Hearst Health Manager, Strategy and Business Genentech Los Angeles, CA Development South San Francisco, CA Sutter Health ALEXIS BERNSTEIN SANJAY ANAND San Francisco, CA Senior Director, Client Services President and CEO Wellframe BRIAN CHOI, MD Bryant Ranch Prepack Pharmaceuticals Boston, MA Chief Medical Information Officer; Burbank, CA Associate Professor of Medicine & Radiology KERUN BINDRA NICK ANDERSON George Washington University Director, Global Product & Associate Washington, DC Portfolio Strategy Robert W. Baird AstraZeneca RYAN COCHRAN Chicago, IL Gaithersburg, MD Corporate Strategy HEATHER ASPRAS CarePoint Health System DARREN M. BLACK Director, New Product Strategy Jersey City, NJ Managing Director GlaxoSmithKline Summit Partners TERI CONDON Philadelphia, PA Boston, MA Vice President, Strategy and DARSHAN BACHHAWAT Business Development KATHERINE BOCK Director, Health Systems Business QuantiaMD, a Subsidiary of Senior Director, Corporate Development ZocDoc Physician’s Interactive Nevro New York, NY Waltham, MA Redwood City, CA KENT E. BACKLUND DEREK J. CONOVER, DMD DAVID BRILL Director Dentist Research Analyst Pfizer, Inc. Noble Dental Conover, Everpoint Asset Management New York, NY Leonard and Associates New York, NY Philadelphia, PA BRENDA J. BACON ELIZABETH J. CAMPBELL President and CEO ANA CRESPO Vice President Brandywine Senior Living Product Marketing Manager LL Partners Mt. Laurel, NJ SI-BONE, Inc. Philadelphia, PA San Jose, CA TONY BALDA NICOLE A. CARKNER President & COO LISA DAVID Executive Director Medicomp, Inc. President and CEO Quad City Health Initiative , FL Public Health Solutions Davenport, IA New York, NY GRANT BECHTOLD WILLIS CHANDLER Vice President, Corporate and Business MORLI DESAI Vice President Health System Alliances Development Director of Strategy and Commercialization CVS Health Medsurant Holdings (portfolio co. Medtronic (Division: Surgical Innovations Cumberland, RI New Capital/Volante Capital) Value Segment) Santa Monica, CA Atlanta, GA THIERRY CHAUCHÉ Executive Director, Business Planning JAMIL M. BEG SALIL V. DESHPANDE, MD & Analysis Director of Business Development Chief Medical Officer Novartis Pharmaceuticals Corporation SAGE Therapeutics UnitedHealthcre Community Plan of Texas East Hanover, NJ Cambridge, MA Sugar Land, TX

34 PITAMBER “PITOU” DEVGON, MD TOMMY (YINING) FU, MD JERRY HSU President, Co-Founder Resident Physician - Emergency Medicine Manager Velano Vascular, Inc. Duke University Hospital Deloitte Consulting Philadelphia, PA Durham, NC San Francisco, CA

SUJIT DIKE ADRIAN GALE ROB A. HULICK Area Vice President, Strategic Senior Manager, Marketing Vice President Account Management Nevro Corp. Alleghany Capital Corporation Johnson & Johnson Redwood City, CA New York, NY Eagleville, PA J.P. GALLAGHER OREN K. ISACOFF, MD TANIA DIMITROVA Chief Operating Officer Vice President Director, Worldwide Business Development NorthShore University HealthSystem Longitude Capital Pfizer Inc. Evanston, IL Greenwich, CT New York, NY MIKE GALLAGHER DANIEL J. KARP BEN DORANZ, PHD Principal VP, Worldwide Business Development President and Chief Executive Officer H.I.G. Capital Pfizer, Inc. Integral Molecular, Inc. Miami, FL New York, NY Philadelphia, PA ALLISON GAW JOYCE KIM MINA KHOSRAVI EGAN Director, Scientific and Manager, Service Line Performance Managing Director, Corporate Development Improvement & Data Analysis Population Health Solutions ProNAi Therapeutics Main Line Health The Advisory Board Company , BC Bryn Mawr, PA Washington, DC SEAN GLEESON, MD MICHAEL KOBY RAMI ELGHANDOUR President Partner President Partners For Kids, 1315 Capital Nevro Corp. Nationwide Children’s Hospital Philadelphia, PA Redwood Shores, CA Columbus, OH MICHAEL KRAUTKRAMER MYRIAM EXUMÉ BRIAN P. GOLDSTEIN, MD Vice President Operations US Marketing Leader, CV Franchise Executive Vice President and Avid Radiopharmaceuticals Merck Chief Operating Officer Philadelphia, PA North Wales, PA UNC Hospitals Chapel Hill, NC DAVID LAMACCHIA DANIEL FAGA Vice President, Corporate Development Chief Business Officer GARY L. GOTTLIEB. MD Prospira PainCare Spark Therapeutics President and Chief Executive Officer Roswell, GA Philadelphia, PA Partners in Health Boston, MA RICHARD LEE, MD SAMUEL S. FAGER, MD, JD Assistant Professor President VIKAS GOYAL Weill Cornell Medical College S.S. Fager Consulting, Inc. Principal New York, NY Villanova, PA SR One Cambridge, MA ADAM LESSLER, MD MICHAEL FAZEKAS Vice President Vice President TODD GUREN Canepa Healthcare, LLC Flexpoint Ford Assistant Director, Product Management New York, NY Chicago, IL Regence BlueCross BlueShield Portland, OR LAUREN LISHER DOUGLAS FISHER, MD Principal Partner ALISON HAGAN Oxeon Partners InterWest Partners Principal New York, NY Menlo Park, CA Deloitte Consulting San Francisco, CA JEFFREY LITWIN, MD PETER FISHMAN President Director of Clinical Integration LINDSAY RAND HERMAN Litwin Consulting CarePoint Health Program Manager, Strategic Planning West Windsor, NJ Jersey City, NJ & Business Development Northwestern Medicine WENDY LIU AARON FLINK Chicago, IL Senior Director, External Opportunities Principal Pfizer McKesson Ventures VLAD HOGENHUIS, MD New York, NY San Francisco, CA Senior Vice President Pharmaceuticals GlaxoSmithKline JUSTIN LORING ERIC FLYCKT, MD Brentford, London, UK Director, Business Development VP Informatics Natera Jiff Inc. JARED P. HOPKINS Redwood City, CA Mountain View, CA Director, Strategic Finance and Business Consulting GABRIEL LUFT CHRIS FRANCK University of Michigan Health System Vice President Principal, Life Sciences and Health Care Ann Arbor, MI Amulet Capital Partners Deloitte Consulting LLP Greenwich, CT Parsippany, NJ

35 Health Care Program Mentors

ROBERT C. MCDONALD, MD ELIZABETH KIERMAN PATTYN MICHAEL ROVINSKY President Director of Life Sciences Director, Southeast Region Aledo Consulting Truveris Veralon Indianapolis, IN New York, NY Atlanta, GA

KAREN MEADOR, MD JONATHAN PEARLSTEIN JON ROZENFELD Managing Director Director of Growth Marketing President and Chief Operating Officer BDO Consulting Jiff St. Mary’s Hospital New York, NY Oakland, CA Madison, WI

RAJJI MEHDWAN JENNIFER PERRY ANIL SAGGI Head of Marketing and Strategy Vice President, Health Care Category Marketing Manager Genentech Roche Denmark FMG Leading Nordics, Consumer Health Klampenborg, Copenhagen, Denmark San Diego, CA GlaxoSmithKline Consumer Health Solna, Sweden MICHAEL C. MENG CARY G. PFEFFER, MD Principal Partner JOE SCATTERGOOD Apax Partners Third Rock Ventures Senior Marketing Manager, New York, NY Boston, MA Oncology Global Marketing AbbVie AUDREY MEYERS DAVID PINKERT Mettawa, IL President/CEO Co-Founder and COO The Valley Hospital/Valley Health System Canopy Health Insurance, Inc. STEVE SCHRODEL Ridgewood, NJ Denver, CO Vice President, Operations Iora Health GEOFF MEYERSON SALLY POBLETE Boston, MA Managing Director and Co-Founder Founder and CEO Locust Walk Wellthie DAVID M. SCHUPPAN Cambridge, MA New York, NY Partner Cressey & Company LP GREG MILLHAUSER LEN PODOLSKY Chicago, IL Vice President and VP, Partnership Development Portfolio Manager, Private Investments Veterinary Practice Partners JOHN SCHWARZ Glenmede Philadelphia, PA Vice President, Administration Philadelphia, PA Lankenau Medical Center / DARSHAN PRABHU Main Line Health REGAN MURPHY Executive Director Wynnewood, PA VP, Client Success UBS Investment Bank Valence Health New York, NY REBECCA SCHWIETZ Chicago, IL Senior Vice President, Clinical Services HENRY RATH HealthFirst LAURIE MYERS Vice President, Business Development New York, NY Global Health Literacy Director Seres Therapeutics Merck & Co., Inc. Cambridge, MA KENNETH C. SEGARNICK North Wales, PA Chief Corporate Officer DONNA BRADY RAZIANO, MD Brandywine Senior Living TY NELSON Chief Medical Officer Mt. Laurel, NJ EVP Mercy Health System, Mercy Home Health Carousel LLC & Community Health Services ANKIT SHAH Cincinnati, OH Philadelphia, PA Director of Marketing Intersect ENT WES NURSS KATE REED, RN Menlo Park, CA Analyst Chief Strategy Officer Marshall Wace Beth Israel Deaconess Medical Center SHERI SHAPIRO New York, NY Boston, MA Senior Vice President Mergers Acquisitions & Partnerships JAMES O’CONNELL SANDRA RETZKY, DO, JD, RPH, MBA, MPH Trinity Health Start-Up Associate Director/Global Analytics and Detroit, MI Downingtown, PA Intelligence AstraZeneca DAVID SILK JUSTIN PALLARI Gaithersburg, MD Senior Account Executive Chief Executive Officer Google TransformativeMed JAMES RHODES New York, NY Seattle, WA Director, Business Development Children’s Health System of Texas JAMES STANFORD KALYAN PAMARTHY Dallas, TX Managing Director Sr. Product Manager Fitzroy Health LLC Jiff, Inc. BEN M.W. ROOKS New York, NY Mountain View, CA Managing Director ST Advisors, Inc. SUSAN STIMSON SHAUNAK PARIKH San Francisco, CA Vice President of Marketing Vice President & International Sales Essex Woodlands JULIE YOUNG ROTH Intersect ENT New York, NY Director, Oncology, Infusion, Pallative Care Menlo Park, CA Services Line Palo Alto Medical Foundation/Sutter Health Palo Alto, CA

36 JONATHAN TAMIR JOHN VOITH DANIEL YIP Vice Chair, Finance & Administration, Director and Product Manager Head of U.S. Marketing Department. of Medicine athenahealth Intercept Pharmaceuticals Columbia University Medical Center Watertown, MA New York, NY New York, NY DAVID WALTON ELLEN S. YOON AMANDA HOPKINS TIRRELL Chief Commercial Officer Global Cognitive & Analytics Insurance Chief Operating Officer AgaMatrix, Inc. Leader, GBS Partner Georgia Regents Medical Associates Salem, NH IBM Corp. Augusta, GA New York, NY DONG WEI, PHD FERNANDO TORRES Senior Director, Business Operations DEREK H. YUAN, MD Practice Lead and Project Management Director Himformatics Johnson & Johnson PharmaEssentia Corp. Cummings, GA Menlo Park, CA Taipei, Taiwan

BARBARA TROUPIN, MD ANDREW WEISENFELD XIN SHANE ZHANG, PHD SVP, Chief Medical Officer Partner Marketing Director Apricus Biosciences MTS Health Partners Smith&Nephew San Diego, CA New York, NY Andover, MA

MAYA TSUKERNIK CHRIS WILKERSON KEELY ZIPP Project Leader President Director, Commercial Analytics The Boston Consulting Group EquipSystems, LLC Incyte Corp. New York, NY New York, NY Wilmington, DE

JOHN A. URQUHART HELENE WOLK THOMAS ZIPP Vice President Senior Vice President of Operations Marketing Leader, BRILINTA HealthCare Royalty Partners Englewood Hospital and Medical Center AstraZeneca Pharmaceuticals Stamford, CT Englewood, NJ Wilmington, DE

JEFF VOIGT JON YEATMAN Principal Vice President, Strategic Growth Medical Device Consultants and Business Development of Ridgewood Mission Health Ridgewood, NJ Asheville, NC

Administration

GEOFFREY M. GARRETT, PH.D. Dean, The Wharton School

HOWARD KAUFOLD, PH.D. Vice Dean and Director, The Wharton Graduate Division

SCOTT E. HARRINGTON, PH.D. Chair, Health Care Management Department, The Wharton School; Director, MBA Program in Health Care Management

JUNE M. KINNEY, M.A. Associate Director, MBA Program in Health Care Management

CHRISTINE ALESZCZYK Administrative Coordinator, MBA Program in Health Care Management

JANICE SINGLETON Administrative Coordinator, MBA Program in Health Care Management

37 Faculty

The Program Faculty are drawn from EZEKIEL J. EMANUEL, M.D., PH.D. JUNE M. KINNEY, M.A. the Wharton School, the School of Diane v.S. Levy and Robert M. Associate Director, Graduate Program Levy University Professor and in Health Care Management; Medicine, the School of Nursing, and Vice Provost for Global Initiatives; Lecturer, Health Care Management, the School of Arts and Sciences at the Professor, Health Care Management, The Wharton School University of Pennsylvania and leading The Wharton School GARY J. KURTZMAN, M.D. health institutions in Philadelphia. BRADLEY M. FLUEGEL Vice President, Life Sciences, Additional support is provided by the Senior VP & Chief Strategy Safeguard Scientifics; Lecturer, Officer, Walgreens; Health Care Management, Fellows and Associates of the Leonard Lecturer, Health Care Management, The Wharton School Davis Institute of Health Economics. The Wharton School JEFFREY P. LIBSON, J.D. THOMAS N. GILMORE, M.ARCH. Partner, LLP; Vice President, Lecturer, Health Care Management, The Center for Applied Research Inc.; The Wharton School ABBY E. ALPERT, PH.D. Senior Fellow, Health Care Management, HARI MAHADEVAN, PH.D. Assistant Professor, The Wharton School Health Care Management, Independent Consultant; The Wharton School JOHN P. GLASER, PH.D. Lecturer and Senior Fellow, Senior Vice President, Client Health Care Management, EUGENIO ANESSI, PH.D. Administration, Cerner Corporation; The Wharton School Professor, Public Management, Lecturer, Health Care Management STEVEN A. NICHTBERGER, M.D. Bocconi University Graduate School The Wharton School of Management, Milan, Italy; Adjunct Professor and Senior Fellow, Lecturer and Senior Fellow, HENRY A. GLICK, PH.D. Health Care Management, Health Care Management, Professor of Medicine, The Wharton School The Wharton School Perelman School of Medicine at MITESH S. PATEL, M.D. the University of Pennsylvania; Assistant Professor of Medicine, Perelman DAVID A. ASCH, M.D., M.B.A. Professor, Health Care Management, School of Medicine at the University Executive Director, The Wharton School Penn Medicine Center for Health of Pennsylvania School of Medicine; Care Innovation; MATTHEW R. GRENNAN, PH.D. Assistant Professor of Health Care Professor of Medicine, Assistant Professor, Management, The Wharton School Perelman School of Medicine Health Care Management, MARK V. PAULY, PH.D. at the University of Pennsylvania; The Wharton School John M. and Thomas L. Bendheim Professor, Health Care Management, Professor; Professor, Health Care The Wharton School SCOTT E. HARRINGTON, PH.D. Management, Business Economics and Chair, Health Care Management Public Policy, The Wharton School; THOMAS E. BAKER, J.D. Department, and Director, Professor, Economics, College of Arts William Maul Measey Professor of Health Care Management Program, and Sciences Law and Health Sciences, University The Wharton School of Pennsylvania Law School; Alan B. Miller Professor of Health Care WILLIAM P. PIERSKALLA, PH.D. Professor of Health Care Management, Management and Business Economics Professor Emeritus The Wharton School and Public Policy, The Wharton School DANIEL POLSKY, PH.D. LAWTON R. BURNS, PH.D., M.B.A. ERIC M. HEIL Robert D. Eilers Professor of Health Care James Joo-Jin Kim Professor of Health SVP, Chief Commercial Officer Management and Economics, Care Management, The Wharton School; Software Solutions, NaviHealth, Inc.; The Wharton School; Faculty Co-Director, Lecturer, Health Care Management, Professor of Medicine, Roy and Diana Vagelos Program The Wharton School Perelman School of Medicine In Life Sciences & Management at the University of Pennsylvania; JOHN C. HERSHEY, PH.D. Executive Director, Leonard Davis PATRICIA M. DANZON, PH.D. Anheuser-Busch Professor Emeritus Institute of Health Economics Celia Z. Moh Professor Emeritus of Management Science; and of Health Care Management, Health Care Management, The Wharton School The Wharton School

GUY DAVID, PH.D. JOHN KIMBERLY, PH.D. Associate Professor, Henry Bower Professor of Entrepreneurial Health Care Management, Studies; Professor of Management, The Wharton School Health Care Management, and Sociology, The Wharton School BENJAMIN DORANZ, PH.D., M.B.A. President and CEO, Integral Molecular, Inc.; Senior Fellow, Health Care Management, The Wharton School

38 DOUGLAS A. PRESENT, M.B.A. RACHEL M. WERNER, M.D., PH.D Investor and Advisor; Associate Professor of Medicine, Lecturer, Health Care Management, Perelman School of Medicine at the The Wharton School University of Pennsylvania School of Medicine; Associate Professor and Senior ARNOLD J. ROSOFF, J.D. Fellow, Operations and Information Professor Emeritus, Management, Health Care Management, Legal Studies and Business Ethics; The Wharton School Lecturer, Health Care Management, The Wharton School JOHN J. WHITMAN, M.B.A. Executive Director, The TRECS Institute; STEPHEN M. SAMMUT Lecturer, Health Care Management, Lecturer and Senior Fellow, The Wharton School Health Care Management, Lecturer, Entrepreneurial Programs, SANKEY V. WILLIAMS, M.D. The Wharton School Professor of General Internal Medicine; Professor, CYNTHIA SCALZI, M.N., PH.D. Health Care Management, Professor Emeritus of Nursing The Wharton School and Health Care Management, The Wharton School

J. SANFORD SCHWARTZ, M.D. Leon Hess Professor in Internal Medicine, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management, The Wharton School

JEFFREY H. SILBER, M.D., PH.D. Director, Center for Outcomes Research, The Children’s Hospital of Philadelphia; Professor of Pediatrics and Anesthesiology & Critical Care, The University of Pennsylvania Perelman School of Medicine at values diversity and seeks talented the University of Pennsylvania; students, faculty and staff from diverse Professor, Health Care Management, backgrounds. The University of The Wharton School Pennsylvania does not discriminate on the basis of race, sex, sexual JEFFREY A. SOLOMON, M.D., M.B.A. orientation, gender identity, religion, Founding Partner, Infiniti Medical LLC; color, national or ethnic origin, age, Lecturer, Health Care Management, JUNE KINNEY disability, or status as a Vietnam Era The Wharton School Associate Director, MBA Program Veteran or disabled veteran in the in Health Care Management administration of educational policies, ASHLEY SWANSON, PH.D. The Wharton School programs or activities; admissions Assistant Professor, policies; scholarship and loan awards; Health Care Management, athletic, or other University adminis- The Wharton School tered programs or employment. KEVIN G.M. VOLPP, M.D., PH.D. Questions or complaints regarding Director, Center for Health Incentives this policy should be directed to: and Behavioral Economics, Executive Director, Leonard Davis Institute; Office of Affirmative Action Professor of Medicine, and Equal Opportunity Programs Perelman School of Medicine Sansom Place East at the University of Pennsylvania; 3600 Chestnut Street, Suite 228 Professor, Health Care Management, Philadelphia, PA 19104-6106 The Wharton School 215.898.6993 (Voice) 215.898.7803 (TDD)

©2004, The Trustees of the University of Pennsylvania. All rights reserved.

SCOTT E. HARRINGTON, PH.D. Director, MBA Program in Health Care Management, Photography of Students: adamgierkephotography.com The Wharton School Book Design: www.HollisterCreative.com

39 Wharton The Wharton School University of Pennsylvania

MBA Program in Health Care Management 3641 Locust Walk Philadelphia, PA 19104-6218

215.898.6861 fax 215.573.2157